Selection from HEOR Bibliography

IMS logo
Search criteria
Condition: Health economics
 
Burden of Hospitalizations and Outpatient Visits Associated With Moderate and Severe Acute Graft-Versus-Host Disease in Finland and Sweden: A Real-World Data Analysis
Authors: Lorenzo Sabatelli, PhD,1 Mikko Keränen, MD, PhD,2 Elisabet Viayna, PhD,3 Montserrat Roset, BSc Stats,3 Nuria Lara, MD, MSc,3 Daniel Thunström, MSc Pharm,1 Minja Pfeiffer, PhD,1 Malin Nicklasson, MSc Pharm,4 Maija Itälä-Remes, MD, PhD5
Affiliations: "1Incyte Biosciences International Sàrl, Morges, Switzerland; 2Helsinki University Hospital, Helsinki, Finland; 3IQVIA Real World Solutions, Barcelona, Spain; 4Department of Hematology and Coagulation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5Turku University Hospital, Turku, Finland "
Publications: 
Supportive Care in Cancer
Document Types: , Article
Countries: , Finland, Spain, Sweden, Switzerland
Condition Year Language Analysis type
, Health economics, Transplant 2022 English , Clinical setting: hospital, Observational study, Population Based Study
 
 
Cost analysis of sequencing new agents for the treatment of chronic lymphocytic leukemia from the perspective of the Brazilian supplementary health system
Authors: Leandro Brust (1), Celso Arrais (2), Fabiano Pombo (3), Diego Kashiura (4), Pedro Vitor Pereira Lima (4), Ana Travassos (5), Rafael Silva (5), Straus Tanaka (5)
Affiliations: 1: Dasa, Rio Grande do Sul, Brasil; 2: Universidade Federal de São Paulo, São Paulo, SP, Brasil; 3: Américas Centro de Oncologia Integrado, Rio de Janeiro, RJ, Brasil; 4: IQVIA Real World Insights Brazil, São Paulo, SP, Brasil; 5: AbbVie Brasil, São Paulo, SP, Brasil.
Publications: 
J Bras Econ Saúde 2022;14(1):80-8
Document Types: , Article
Countries: , Brazil
Abstract: https://jbes.com.br/wp-content/uploads/2022/05/JBES_141_80-88.pdf
Condition Year Language Analysis type
, Health economics, Hematology 2022 Portuguese , Cost effectiveness
 
 
Direct costs associated with lupus nephritis management in the Private Healthcare System in Brazil: an expert panel perspective
Authors: Danielle O. Silva (1), Nathalie David (1), Bruce Y. Kano (2), Diego Kashiura (2), Odirlei A. Monticielo (3), André Hayata (4), Mariana R. Gazzotti (1), Graziela Bernardino (1)
Affiliations: 1: GSK, Rio de Janeiro, RJ, Brasil; 2: IQVIA Real World Insights, São Paulo, SP, Brazil; 3: Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; 4: Centro de Reumatologia Avançada, São Paulo, SP, Brazil
Publications: 
J Bras Econ Saúde 2022;14(3):232-46
Document Types: , Article
Countries: , Brazil
Abstract: https://jbes.com.br/wp-content/uploads/2022/12/JBES_143-p232-246.pdf
Condition Year Language Analysis type
, Dermatology, Health economics 2022 English , Cost analysis
 
 
Budget impact analysis of Jivi® (damoctocog alfa pegol, BAY 94-9027) in severe Hemophilia A in Japan
Authors: Teruhisa Fujii 1, Yuko Kidoguchi 2, Noriko Takahashi 2, Eric Yu 3, Dilinuer Ainiwaer 3, Aidan Byrne 4 (rwesheorj 3)
Affiliations: 1) Division of Blood Transfusion, Hiroshima University Hospital, Hiroshima, Japan 2) Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) IQVIA UK, London, UK
Publications: 
Journal of Medical Economics
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2021.1875788
Condition Year Language Analysis type
, Health economics 2021 English , Budget impact
 
 
High‑Expenditure Disease in the EU‑28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?
Authors: Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck
Affiliations: Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium
Publications: 
PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4
Document Types: , Article
Countries: , Europe
Abstract: https://link.springer.com/epdf/10.1007/s41669-020-00253-4?sharing_token=k4IP2sUMn4HrAsHs0WBqlPe4RwlQNchNByi7wbcMAY4Tirkz8MqaNXdxznG7LjXgeeOE1lL_TUFtfOXdhNB_IQ05wAS6SyWtTgC3QV4GkZ1V3rKbHAI_lwyKV2fZ5OfrjVrTPTsYaJr4E7ZctQaMI_Yhmg_dNtoFcG1705dWSU4%3D
Condition Year Language Analysis type
, Diabetes, Health economics, Oncology 2021 English , Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review
 
 
Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands
Authors: Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, Renée Michels 3, Marieke Krol 3
Affiliations: 1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com. 2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. 3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands.
Publications: 
1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands
BMC Health Services Research (2021) 21:227
PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7
Document Types: , Article
Countries: , Netherlands
Abstract: https://pubmed.ncbi.nlm.nih.gov/33712010/
Condition Year Language Analysis type
, Health economics, Health status & patient reported outcomes, Immunology and Vaccination 2021 English , Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research
 
 
The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
Authors: Lars Holger Ehlers 1, Mark Lamotte 2, Sofia Monteiro 3, Susanne Sandgaard 4, Pia Holmgaard 4, Evan C Frary 4, Niels Ejskjaer 5 6 7
Affiliations: 1Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 2IQVIA Real World Solutions, Zaventem, Belgium. 3IQVIA Real World Solutions, London, UK. 4Boehringer Ingelheim Danmark A/S, København Ø, Hovedstaden, Denmark. 5Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. n.ejskjaer@rn.dk. 6Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk. 7Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk.
Publications: 
Diabetes Therapy https://doi.org/10.1007/s13300-021-01040-y
IQVIA HEOR Zaventem Brussels
PMID: 33856655 PMCID: PMC8099952 DOI: 10.1007/s13300-021-01040-y
Document Types: 
Countries: , Denmark
Abstract: https://pubmed.ncbi.nlm.nih.gov/33856655/
Condition Year Language Analysis type
, Diabetes, Health economics 2021 English , Clinical setting: Primary care, Cost effectiveness
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
Authors: Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, Sérgia Rocha 5, Ana Catarina Fonseca 6, Ana André 7, Ricardo Melo 8, Eduard Sidelnikov 9
Affiliations: 1Department of Cardiology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 2IQVIA, Zaventem, Belgium. 3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com. 4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal. 5Department of Cardiology, Hospital de Braga, Braga, Portugal. 6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal. 7Department of Neurology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 8Amgen SA, Portugal. 9Amgen (Europe) GmbH, Rotkreuz, Switzerland.
Publications: 
PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019 IQVIA HEOR Zaventem Brussels
Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115.
Document Types: , Article
Countries: , Portugal
Abstract: https://pubmed.ncbi.nlm.nih.gov/33581948/
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2021 English , Burden of illness, Clinical setting: Primary care, Prospective study
 
 
Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China
Authors: Ahmed Salem 1, Peng Men 2 3, Mafalda Ramos 4, Yan-Jun Zhang 5, Anastasia Ustyugova 6, Mark Lamotte 7
Affiliations: 1IQVIA, Real World Solutions, Zaventem 1930, Belgium. 2Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China. 3Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China. 4IQVIA, Global HEOR, Porto Salvo 2740-266, Portugal. 5Boehringer Ingelheim, Health Economics & Outcomes Research, Government Affairs & Market Access, Shanghai 200040, China. 6Boehringer Ingelheim, CardioMetabolism Respiratory, Ingelheim am Rhein 55216, Germany. 7IQVIA, Global HEOR, Zaventem 1930, Belgium.
Publications: 
Journal of Comparative Effectiveness Research 2021 https://doi.org/10.2217/cer-2020-0284.
PMID: 33576249 DOI: 10.2217/cer-2020-0284
Document Types: , Article
Countries: , China
Abstract: https://pubmed.ncbi.nlm.nih.gov/33576249/
Condition Year Language Analysis type
, Diabetes, Health economics 2021 English , Clinical setting: Primary care, Cost effectiveness
 
 
Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
Authors: Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
Affiliations: 1Real World Evidence, IQVIA, Zaventem, Belgium. 2R&D China, AstraZeneca R&D, Shanghai, China. 3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo. #Contributed equally.
Publications: 
BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
Document Types: , Article
Countries: , Belgium, China
Abstract: https://pubmed.ncbi.nlm.nih.gov/33910947/
Condition Year Language Analysis type
, Health economics, Respiratory disease 2021 English , Clinical setting: Primary care, Cost effectiveness
 
 
A novel decision model to predict the impact of weight management interventions: The Core Obesity Model.
Authors: Sandra Lopes 1, Henrik H Meincke 1, Mark Lamotte 2, Anamaria-Vera Olivieri 3, Michael E J Lean 4
Affiliations: 1Novo Nordisk A/S Søborg Denmark. 2IQVIA Zaventem Belgium. 3IQVIA Basel Switzerland. 4Human Nutrition School of Medicine, Dentistry and Nursing Royal Infirmary University of Glasgow Glasgow UK.
Publications: 
Obesity Science & Practice 2021. https://doi.org/10.1002/osp4.495
Document Types: , Article
Countries: , Belgium, Switzerland
Abstract: https://pubmed.ncbi.nlm.nih.gov/34123394
Condition Year Language Analysis type
, Health economics, Obesity 2021 English , Clinical setting: Primary care, Cost effectiveness
 
 
Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Authors: Colombo GL, Heiman F, Peduto I
Affiliations: Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publications: 
Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Types: , Article
Countries: , Italy
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072261/pdf/tcrm-17-345.pdf
Condition Year Language Analysis type
, Health economics, Overactive bladder 2021 English , Clinical setting: Primary care, Cost of illness
 
 
Cost-effectiveness analysis of the treatment strategies with or without opioid medications in surgery-eligible patients with osteoarthritis in Japan
Authors: Tomoyuki Takura 1, Akira Yuasa 2, Naohiro Yonemoto 2, Sven Demiya 3, Hiroyuki Matsuda 3, Nozomi Ebata 4, Koichi Fujii 4, Muneaki Ishijima 5 (rwesheorj 3)
Affiliations: 1) Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 2) Health and Value, Pfizer Japan Inc., Shinjuku Bunka Quint Building, 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) Medical Affairs, Pfizer Japan Inc, Tokyo, Japan 5) Department of Medicine for Orthopaedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo, Japan
Publications: 
PharmacoEconomics - Open
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s41669-021-00292-5
Condition Year Language Analysis type
, Health economics 2021 English , Cost effectiveness, Literature Review
 
 
Analisi di impatto sul budget sanitario italiano di gilteritinib per il trattamento della leucemia mieloide acuta FLT3+ recidivante o refrattaria
Authors: Fiorentino F, La Malfa P, Di Rienzo P
Affiliations: Fiorentino F: IQVIA Solutions Italy Srl, RWS
Publications: 
GIHTAD (2021) 14:4
Document Types: , Article
Countries: , Italy
Abstract: https://springerhealthcare.it/GIHTAD/2021/07/05/analisi-di-impatto-sul-budget-sanitario-italiano-di-gilteritinib-%E2%80%A8per-il-trattamento-della-leucemia-mieloide-acuta-flt3-recidivante-%E2%80%A8o-refrattaria/
Condition Year Language Analysis type
, Health economics, Oncology 2021 Italian , Budget impact, clinical setting: Secondary care
 
 
Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Authors: Colombo GL, Heiman F, Peduto I
Affiliations: Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publications: 
Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Types: , Article
Countries: , Italy
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072261/pdf/tcrm-17-345.pdf
Condition Year Language Analysis type
, Health economics, Orthopedics 2021 English , Clinical setting: Primary care, Cost of illness, Retrospective database analysis
 
 
Trifluridine/tipiracil hydrochloride in the treatment of polytreated metastatic colorectal carcinoma: a cost-effectiveness analysis in the private payer perspective in Brazil
Authors:  Fernando Meton de Alencar Camara Vieira (1); Ana Paula Ornellas de Souza Victorino (1); Kelly Borges Araújo (1); Bianca Oesterreicher (2); Pedro Vitor Pereira Lima (2); Luciana Calvo Mardegan (3); Sandro Albuquerque (3); Juliana Simões Festa de Vasconcellos (3)
Affiliations: 1: Instituto COI de Educação e Pesquisa, Rio de Janeiro, RJ, Brasil; 2: IQVIA Solutions, Real World Insights, São Paulo, SP, Brasil; 3: Laboratórios Servier, Rio de Janeiro, RJ, Brasil.
Publications: 
Document Types: , Article
Countries: , Brazil
Abstract: https://jbes.com.br/wp-content/uploads/2022/01/DOI_10_21115_JBES_v13_n3_p242-52.pdf
Condition Year Language Analysis type
, Health economics, Oncology 2021 Portuguese , Cost effectiveness
 
 
Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Authors: Masakazu Yamada 1, Tadashi Nakano 2, Hiroyuki Matsuda 3, Seok-Won Kim 3, Yasutaka Takagi 4 (rwesheorj 3)
Affiliations: 1) Department of Ophthalmology, Kyorin University School of Medicine, Mitaka, Japan 2) Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan 3) Real World Evidence Solutions, IQVIA solutions Japan, Tokyo, Japan 4) Japan Medical Affairs Group, Santen Pharmaceutical Co., Ltd, Osaka, Japan
Publications: 
Journal of Medical Economics
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1804392
Condition Year Language Analysis type
, Health economics 2020 English , Budget impact, Cost effectiveness
 
 
Evaluation of the optimal position for vedolizumab in the Japanese treatment paradigm for ulcerative colitis using Markov modeling
Authors: Akihito Uda 1, Yuki Eto 1, Yuxin Li 2, Hiroyuki Matsuda 3, Sven Demiya 3, Tomoyuki Watanabe 1, Mihoko Ota 1, Ryuichi Iwakiri 1, Ataru Igarashi 4 5 (rwesheorj 3)
Affiliations: 1) Japan Medical Office, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan 2) IQVIA Solutions UK Ltd., London, UK 3) IQVIA Solutions Japan KK, Tokyo, Japan 4) Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan 5) Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan
Publications: 
Crohn's & Colitis 360
Document Types: , Article
Countries: , Japan
Abstract: https://academic.oup.com/crohnscolitis360/article/2/2/otaa017/5809344
Condition Year Language Analysis type
, Health economics 2020 English , Budget impact, Cost effectiveness, Economic evaluation
 
 
Investigation of factors considered by health technology assessment agencies in eight countries
Authors: Akira Yuasa 1 2, Naohiro Yonemoto 1, Sven Demiya 3, Chihiro Foellscher 3, Shunya Ikeda 2 (rwesheorj 3)
Affiliations: 1) Pfizer Japan Inc, Tokyo, Japan 2) Graduate School of Medicine, International University of Health and Welfare, 1-26, Akasaka 4-chome, Minato-ku, Tokyo, 107-8402, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: 
PharmacoEconomics - Open
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007%2Fs41669-020-00235-6
Condition Year Language Analysis type
, Health economics 2020 English , Economic evaluation
 
 
RWE is the Future of Clinical Research: Time to Get Onboard
Authors: Nancy A. Dreyer,
Affiliations: Chief Scientific Officer and Senior VP, IQVIA Real World Solutions
Publications: 
PharmaVOICE - March 2020
Document Types: , Article
Countries: , USA
Abstract: https://www.pharmavoice.com/article/2020-03-rwe-research/#:~:text=We've%20been%20talking%20about,tools%20are%20coming%20into%20use.
Condition Year Language Analysis type
, Health economics, Health status & patient reported outcomes 2020 English , Economic evaluation, Literature Review, Market impact
 
 
Multicenter Prospective Evaluation of Parenteral Nutrition Preparation Time and Resource Utilization: 3-Chamber Bags Compared With Hospital Pharmacy-Compounded Bags
Authors: Sarah V Cogle 1 2, Robert G Martindale 3, Mafalda Ramos 4, Gregory J Roberti 5, Pamela R Roberts 6, Kaci Taylor 7, Gordon S Sacks 1 8
Affiliations: 1Department of Pharmacy Practice, Auburn University, Auburn, Alabama, USA. 2Department of Pharmacy, East Alabama Medical Center, Opelika, Alabama, USA. 3Department of Surgery, Oregon Health and Science University, Portland, Oregon, USA. 4IQVIA, Zaventem, Belgium. 5Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA. 6Department of Anesthesiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA. 7Department of Pharmacy, OU Medical Center, Oklahoma City, Oklahoma, USA. 8Medical Affairs, Fresenius Kabi, LLC, Lake Zurich, Illinois, USA.
Publications: 
Journal of Parenteral and Enteral Nutrition Volume 0 Number 0 November 2020 1–7 DOI: 10.1002/jpen.2045
PMID: 33188572 DOI: 10.1002/jpen.2045
Document Types: 
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33188572/
Condition Year Language Analysis type
, Health economics, Neurological disorders 2020 English , Clinical setting: hospital, Cost effectiveness, Prospective study
 
 
Cost-effectiveness of empagliflozin compared with liraglutide based on cardiovascular outcome trials in Type II diabetes
Authors: Mafalda Ramos 1, Anastasia Ustyugova 2, Nikco Hau 3, Mark Lamotte 4
Affiliations: 1IQVIA Global HEOR, Porto Salvo 2740-266, Portugal. 2Boehringer Ingelheim International GmbH, TA CardioMetabolism Respiratory, Binger Str 173, Ingelheim am Rhein 55216, Germany. 3Boehringer Ingelheim Ltd, UK Market Access, Bracknell RG128YS, UK (at the time of the study). 4IQVIA, Global HEOR, Zaventem 1930, Belgium.
Publications: 
Journal of Comparative Effectiveness Research 2020. https://doi.org/10.2217/cer-2020-0071
PMID: 32573253 DOI: 10.2217/cer-2020-0071
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32573253/
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK
Authors: Mafalda Ramos 1, Michael H Cummings 2, Anastasia Ustyugova 3, Syed I Raza 4, Shamika U de Silva 4, Mark Lamotte 5
Affiliations: 1Global HEOR/Real World Solutions, IQVIA, 2740-266, Porto Salvo, Portugal. 2Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth, PO6 3LY, Hampshire, UK. 3Boehringer Ingelheim International GmbH, 55216, Ingelheim Am Rhein, Germany. 4Boehringer Ingelheim Ltd., Bracknell, RG12 8YS, Berkshire, UK. 5Global HEOR/Real World Solutions, IQVIA, 1930, Zaventem, Belgium. Mark.lamotte@iqvia.com.
Publications: 
Diabetes Therapy 2020; 11(9), 2041-2055; https://doi.org/10.1007/s13300-020-00883-1.
PMID: 32700188 PMCID: PMC7434815 DOI: 10.1007/s13300-020-00883-1
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32700188/
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
External Validation of the Core Obesity Model to Assess the Cost Effectiveness of Weight Management Interventions
Authors: Sandra Lopes 1, Pierre Johansen 2, Mark Lamotte 3, Phil McEwan 4, Anamaria-Vera Olivieri 5, Volker Foos 4
Affiliations: 1Novo Nordisk A/S, Søborg, Denmark. snlb@novonordisk.com. 2Novo Nordisk A/S, Søborg, Denmark. 3IQVIA, Zaventem, Belgium. 4Health Economics and Outcomes Research Ltd, Cardiff, UK. 5IQVIA, Basel, Switzerland.
Publications: 
Pharmacoeconomics 2020 https://doi.org/10.1007/s40273-020-00941-3 + Pharmacoeconomics. 2021 Jan;39(1):137-138. doi: 10.1007/s40273-020-00982-8. Epub 2020 Nov 30
Document Types: , Article
Countries: , Belgium, Denmark, Switzerland, UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32656686/
Condition Year Language Analysis type
, Health economics, Obesity 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?
Authors: Monteiro S, Ramos M, Lamotte M
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
ISPOR US 2020 Orlando. Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB44.
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
IMPACT OF USING DIFFERENT TYPES OF HBA1C PROGRESSION IN THE IQVIA CORE DIABETES MODEL.
Authors: Ramos M, Monteiro S, Lamotte M
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52.
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
Three Asian Type 2 Diabetes cardiovascular risk equations simulation using the IQVIA Core Diabetes Model
Authors: Ryo Mitsuo 1, Sven Demiya 1, Adeeb Tawseef 1, Raf De Moor 1, M Ramos, M Lamotte (rwesheorj 1)
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
Japan Diabetes Society 2020 Annual Meeting
Document Types: , Poster
Countries: , Asia Pacific, Japan
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL.
Authors: Ramos M, Monteiro S, Olivieri AV, Lamotte M.
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
ISPOR US 2020 Orlando. Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB56
Document Types: , Poster
Countries: , Asia Pacific
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
Does Including EGFR Along to HBA1C As a Driver of Treatment Switch Changes Outcomes in Cost-Effectiveness Analyses in Type 2 Diabetes?
Authors: Ramos M, Monteiro S, Lamotte M
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 108179.
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
The Cost-Effectiveness of Empagliflozin in Type 2 Diabetes in Denmark, Incorporating Cardiovascular Outcomes
Authors: Ehlers LH, Lamotte M, Monteiro S, Sandgaard S, Holmgaard P, Frary EC, Staehr P, Ejskjaer N.
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107114
Document Types: , Poster
Countries: , Denmark
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
Cost-Effectiveness of the FreeStyle Libre System versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Treatment not Reaching Glycemic Goals in Sweden.
Authors: Jendle J, Eeg-Olofsson K, Svensson AM, Franzen S, Lamotte M, Levrat-Guillen F.
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: 
American Diabetes Association’s (ADA’s) 81st Scientific Sessions. Poster presentation number 135-LB
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Diabetes, Health economics 2020 English , Clinical setting: Primary care, Cost effectiveness
 
 
Cost-utility model for 2nd generation treatment of chronic HCV in general population: impact of EASL recommendations in 2016 and 2018
Authors: Natlia Pascual-Argent (1,2); Carlos Crespo (1,3); Laura Planellas (4); Mriam Solozabal (4), Nria Perulero (4); Jaume Puig-Junoy (1,2)
Affiliations: (1) UPF Barcelona School of Management; (2) Dept. Economa y Empresa CRES UPF; (3) Universitat de Barcelona; (4) HEOR-RWE, IQVIA Spain
Publications: 
XXXIX Jornadas de Economa de la Salud. Albacete, 12 al 14 de junio de 2019
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Infectious disease 2019 Spanish , Clinical setting: hospital, Cost effectiveness
 
 
Health economic effects of the updated foot ulcer submodel
Authors: Monteiro S1, Ramos M2, Lamotte M2
Affiliations: 1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , UK
Abstract: https://doi.org/10.1016/j.jval.2019.09.899
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Cost effectiveness
 
 
The clinical and economic impact of adding an adherence module to the IQVIAcore diabetes model
Authors: Ramos M1, Monteiro S2, Altrabsheh E2, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Germany
Abstract: https://doi.org/10.1016/j.jval.2019.09.943
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Cost effectiveness, Survey research
 
 
The cost effectiveness of Enoxaparin in the previon of venous thromboembolism in patients undergoing major surgery in Egypt
Authors: Farag A1, Abdel Moety H1, Hassan L2, Pathak P3, Lamotte M4, Levorsen A5
Affiliations: 1 Cairo University, Cairo, Egypt 2 Alexandria University, Alexandria, Egypt 3 IQVIA, Dubai, United Arab Emirates 4 IQVIA, Zaventem, Belgium 5 Sanofi, Global, France
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Egypt
Abstract: https://doi.org/10.1016/j.jval.2019.09.2604
Condition Year Language Analysis type
, Health economics, Orthopedics 2019 English , Cost effectiveness
 
 
Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients
Authors: Goodall G1, Lamotte M2, Ramos M2, Maunoury F3, Pejchalova B1, de Pouvourville G4
Affiliations: 1 Edwards Lifesciences S.A., Nyon, Switzerland 2 IQVIA, Zaventem, Belgium 3 Statesia, Le Mans, France 4 ESSEC Business School, Cergy Pontoise, France
Publications: 
J Med Econ. 2019 Apr;22(4):289-296. doi: 10.1080/13696998.2018
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30547704
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2019 English , Cost effectiveness
 
 
Health economic value of blood in Ivory coast: The case of maternal bleeding
Authors: Sekongo YM1, Asamoah-Akuoko L2, Owusu-Ofori SPO3, Lamotte M4, Bah A5, Dierick K5
Affiliations: 1 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan,Yvory Coast 2 National Blood Service, Accra, Ghana 3 Komfo Anokye Teaching Hospital, Kumasi, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Ivory Coast
Abstract: https://doi.org/10.1016/j.jval.2019.09.1429
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Literature Review
 
 
Health economic vale of blood in Ghana: The case of maternal bleeding
Authors: Owusu-Ofori SPO1, Asamoah-Akuoko L2, Lamotte M3, Bah A4, Dierick K4
Affiliations: 1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 National Blood Service, Accra, Ghana 3 IQVIA, Zaventem, Belgium 4 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: 
Abstract: https://doi.org/10.1016/j.jval.2019.09.1964
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Survey research
 
 
Health economic value of blood in Sub-Saharan: The case of maternal bleeding
Authors: Owusu-Ofori SPO1, Sekongo YM2, Rajab JA3, Asamoah-Akuoko L4, Magutu V5, Lamotte M6, Bah A7, Dierick K7
Affiliations: 1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan, Yvory Coast 3 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Kenya 4 National Blood Service, Accra, Ghana 5 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 6 IQVIA, Zaventem, Belgium 7 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: 
Abstract: https://doi.org/10.1016/j.jval.2019.09.2059
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Survey research
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Authors: Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5
Affiliations: 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium
Publications: 
Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
Document Types: , Article
Countries: , Belgium, France, Poland, Portugal, Spain, Switzerland, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30955367
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2019 English , Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study
 
 
The value of blood in sub-Saharan Africa
Authors: Magutu V1, Rajab A2, Asamoah-Akuoko L3, Lamotte M4, Bah A5, Dierick K5
Affiliations: 1 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 2 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya 3 National Blood Service, Accra, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: 
Abstract: https://doi.org/10.1016/j.jval.2019.09.2084
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Survey research
 
 
Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
Authors: Lau E1, Salem A2, Chan JCN1, So WY1, Kong A1, Lamotte M2, Luk A1
Affiliations: 1 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, SAR China 2 IQVIA, Zaventem, Belgium
Publications: 
Cost Eff Resour Alloc. 2019 Jul 2;17:13.
Document Types: , Article
Countries: , Hong Kong
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31303866
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Cost effectiveness
 
 
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
Authors: Kent S1, Becker F1, Feenstra T2,3, Tran-Duy A4, Schlackow I1, Tew M4, Zhang P5, Ye W6, Lizheng S7, Herman W6, McEwan P8, Schramm W9, Gray A1, Leal J1, Lamotte M10, Willis M11, Palmer AJ4,12, Clarke P13,14
Affiliations: 1 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK 2 National Institute for Public Health and the Environment (RIVM), Centre for Nutrition, Prevention and Health Services Research, Bilthoven, The Netherlands 3 University of Groningen, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Groningen, The Netherlands 4 Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia 5 Division of Diabetes Translation, Centres for Disease Control and Prevention, Atlanta, US 6 School of Public Health, University of Michigan, Ann Arbor, US 7 Department of Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, US 8 Centre for Health Economics, Swansea University, Swansea, UK 9 GECKO Institute, Heilbronn University, Heilbronn, Germany 10 IQVIA, Zaventem, Belgium 11 The Swedish Institute for Health Economics, Lund, Sweden 12 Menzies Institute for Medical Research, The University of Tasmania, Hobart, Australia 13 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK 14 Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Publications: 
Pharmacoeconomics. 2019 Nov;37(11):1305-1312.
Document Types: , Article
Countries: 
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31347104
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Retrospective database analysis
 
 
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach
Authors: Foos V1, Wang K2, McEwan P3, Zhang Y2, Xin P2, Jiang X2, Qu S4, Xiong T4, De Moor R1, Ramos M1, Lamotte M1, Ji L5
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai, China 3 Centre for Health Economics, Swansea University, Wales, England, UK 4 RWE Solutions & HEOR, QuintilesIMS, Shanghai, China 5 Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China
Publications: 
Value Health Reg Issues. 2019 May;18:36-46.
Document Types: , Article
Countries: , China
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30419449
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Cost effectiveness
 
 
The cost-effectiveness of physical activity in the management of COPD patients in the UK
Authors: Ramos M1, Lamotte M1, Gerlier L1, Svangren P2, Miquel-Cases A3, Haughney J4
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Core Respiratory, Global Product and Portfolio Strategy - Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Mölndal, Sweden 3 Global Price and Reimbursement, Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Cambridge, UK 4 Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Publications: 
Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239
Document Types: , Article
Countries: , Scotland
Abstract: doi: 10.2147/COPD.S181194. eCollection 2019
Condition Year Language Analysis type
, Health economics, Respiratory disease 2019 English , Cost effectiveness
 
 
Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease
Authors: Ramos M1, Foos V1, Ustyugova A2, Hau N3, Gandhi P4, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International GmbH, Ingelheim, Germany 3 Boehringer Ingelheim Ltd, Bracknell, UK 4 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, US
Publications: 
Diabetes Ther. 2019 Dec;10(6):2153-2167
Document Types: , Article
Countries: , UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31602601
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Cost effectiveness
 
 
Advancing glycemic management in people with diabetes
Authors: Aitken M1, Villa P1, Lamotte M1, Tewary V1, Ramos M1
Affiliations: 1 IQVIA, Zaventem, Belgium
Publications: 
with paper on the IQVIA institute web page
Document Types: , Article
Countries: 
Abstract: https://www.iqvia.com/insights/the-iqvia-institute/reports/advancing-glycemic-management-in-people-with-diabetes
Condition Year Language Analysis type
, Diabetes, Health economics 2019 English , Cost effectiveness
 
 
Cost-offsets in relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice
Authors: Ripellino C, Pegoraro V, Heiman F
Affiliations: Ripellino C: HEOR Consultant Freelance, Milan, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publications: 
CLINICO ECONOMICS ITALIAN ARTICLES ON OUTCOMES RESEARCH / VOL 14 / YEAR 2019 / PAG. 55-64
Document Types: , Article
Countries: , Italy
Abstract: http://www.clinicoeconomics.eu/articles/flipbook/14_2019_55-64/
Condition Year Language Analysis type
, Health economics, Oncology 2019 Italian , Cost analysis
 
 
Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China
Authors: Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu
Affiliations: IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai
Publications: 
Journal of Medical Economics
Document Types: , Article
Countries: , China
Abstract: http://www.tandfonline.com/doi/abs/10.1080/13696998.2017.1417312
Condition Year Language Analysis type
, Health economics, Infectious disease 2018 English , Cost effectiveness
 
 
A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
Authors: Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P. A
Affiliations: Baker, Subedi: Pfizer; Ferrufino, Kowal and Tan: IQVIA
Publications: 
ClinicoEconomics and outcomes research
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052927/pdf/ceor-10-359.pdf
Condition Year Language Analysis type
, Health economics 2018 English , Cost benefit
 
 
The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly
Authors: Miao Jiang; Danny Hughes; Wenyi Wang
Affiliations: Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar)
Publications: 
Preventive Medicine
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Health economics, Health policy 2018 English , Observational study, Population Based Study, Public Health, Retrospective cohort analysis
 
 
A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom
Authors: Raluy-Callado M, Cox A, MacLachlan S, Bakheit AM, Moore AP, Dinet J & Gabriel S
Affiliations: Evidera
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Health economics 2018 English , Retrospective database analysis
 
 
Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France
Authors: Clément Le Dissez1, Pascal Paubel2, Frédéric Courbon3, Rémy Herve4, Mark Rance5, Marie-Aude Courteille6
Affiliations: 1IQVIA Opération France, Paris, La Défense ; 2Inserm UMR S 1145, Institut Droit et Santé, faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, 4 avenue de l’observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France
Publications: 
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Clinical practice, Health economics, Oncology 2018 English , Budget impact, Literature Review, Public Health
 
 
LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION.
Authors: Allou A*, Carette J*, Minacori R*, Touahmia S*, Bourguignon S*, Troubat A*, Maurel F*
Affiliations: IQVIA France - RWI
Publications: 
ISPOR 2018
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology 2018 English , Cost effectiveness, Market impact, Review
 
 
WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE.
Authors: Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles
Affiliations: RWI IQVIA France
Publications: 
ISPOR 2018
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases 2018 English , Cost effectiveness, Pricing & Reimbursement, Willingness to pay
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
Authors: Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5
Affiliations: 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France
Publications: 
European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
Document Types: , Poster
Countries: , Belgium, France, Poland, Portugal, Spain, Switzerland, UK
Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2018 English , Burden of illness, Cost of illness
 
 
Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Authors: Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations: 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publications: 
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Types: , Oral presentation
Countries: , Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2018 English , Burden of illness, Cost of illness
 
 
ECONOMIC IMPACT OF THE PATIENT BLOOD MANAGEMENT FROM A FRENCH NATIONAL PAYER AND HOSPITAL PERSPECTIVES IN FRANCE
Authors: Vasilescu L , Champs F-O1, Durand-Zaleski I
Affiliations: 1 IQVIA France - RWI, 2 URCEco - Hôpital de l'Hôtel Dieu, Paris France
Publications: 
ISPOR 2018
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Health economics 2018 English , Budget impact, Economic evaluation
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Authors: Salem A1, Ramos M1, Hu H2, Zhong H3, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 University of Macau, Macau, China 3 AstraZeneca, Shanghai, China
Publications: 
Document Types: , Poster
Countries: , China
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/83455
Condition Year Language Analysis type
, Health economics, Respiratory disease 2018 English , Cost analysis, Cost effectiveness
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Authors: Salem A, Ramos M, Hu H, Zhong H, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: 
ISPOR Asia Pacific, 2018, September 8-11, Tokyo, Japan
Document Types: , Poster
Countries: , China
Condition Year Language Analysis type
, Health economics, Respiratory disease 2018 English , Cost effectiveness
 
 
The cost-effectiveness of physical activity in the management of COPD patients in the UK.
Authors: Ramos M, Lamotte M, Gerlier L, Svangren P, Cases A M, Haughney J
Affiliations: IQVIA, Zaventem, Belgium
Publications: 
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Health economics, Respiratory disease 2018 English , Cost effectiveness
 
 
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling.
Authors: Ramos M, Foos V, McEwan P, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: 
ISPOR 20th Annual European Congress, 2017, November 4-8, Glasgow, Scotland
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2018 English , Cost effectiveness
 
 
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Authors: Palmer AJ1, Si L1, Tew M2, Hua X2, Willis MS3, Asseburg C3, McEwan P4, Leal J5, Gray A5, Foos V6, Lamotte M6, Feenstra T7, 8, O’Connor PC 9, Brandle M 10, Smolen HJ11, Gahn JC11, Valentine WJ12, Pollock RF12, Breeze P13, Brennan A13, Pollard D13, Ye W14, Herman WH15, Isaman DJ14, Kuo S16, Laiteerapong N17, Tran-Duy A2, Clarke PM2
Affiliations: 1 University of Tasmania, Hobart, Tasmania, Australia 2 University of Melbourne, Melbourne, Victoria, Australia 3 The Swedish Institute for Health Economics, Lund, Sweden 4 Health Economics and Outcomes Research Ltd., Cardiff, UK 5 University of Oxford, Oxford, UK 6 IQVIA, Zaventem, Belgium 7 National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands 8 Groningen University, Groningen, The Netherlands 9 HealthPartners Institute and HealthPartners Center for Chronic Care Innovation, Minneapolis, MN, USA 10 Kantonsspital St. Gallen, St. Gallen, Switzerland 11 Medical Decision Modeling Inc., Indianapolis, IN, USA 12 Ossian Health Economics and Communications, Basel, Switzerland 13 University of Sheffield, Sheffield, UK 14 University of Michigan, Ann Arbor, MI, USA 15 University of Michigan, Ann Arbor, MI, USA 16 University of Michigan, Ann Arbor, MI, USA 17 University of Chicago, Chicago, IL, USA
Publications: 
Value in Health, 2018, 21(6): 724-731
Document Types: , Article
Countries: , International
Abstract: https://doi.org/10.1016/j.jval.2018.02.002
Condition Year Language Analysis type
, Diabetes, Health economics 2018 English , Cost effectiveness
 
 
Review and Validation of Cardiovascular Risk Prediction Models in East Asian Populations.
Authors: Foos V, McEwan P, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: 
Value in Health, Volume 21, Supplement 1, May 2018, Page S220
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2018 English , Cost effectiveness
 
 
Comparative Analysis of the Market Penetration of Personalised Medicine Drugs Under the Conditions of AMNOG
Authors: Fischer T, Bonduelle D, Antoni B
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications: 
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Health economics, Health policy 2018 German , Market impact
 
 
Overview of German AMNOG Dossiers with Price Analysis Before and After Early Benefit Assessment
Authors: Tremmel M, Batscheider A, Bocuk D, Roxlau T, Antoni B, Elena Mihaylova, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany IQVIA RDS Bulgaria EOOD, Sofia, Bulgaria
Publications: 
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Health economics, Health policy, Pricing and reimbursement 2018 English , Pricing & Reimbursement, Review
 
 
The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases
Authors: Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications: 
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement 2018 English , Cost analysis, Pricing & Reimbursement
 
 
DERMATOLOGY AS AN EXAMPLE Originator and Generic Market Access Pretection Strategies in Germany Using Dermatology as an Example
Authors: Greiner RA, Antoni B, Batscheider A, Bonduelle D Roxlau T, Stratil AS
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications: 
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Dermatology, Health economics 2018 English , Market impact
 
 
Duration of Inability to Work in Depression Patients Treated in General or Psychiatric Practices in Germany
Authors: Kostev K, Dombrowski S, Konrad M, Bohlken J
Affiliations: IQVIA, Frankfurt am Main, Germany FOM University of Applied Sciences, Frankfurt am Main, Germany Praxis für Neurologie und Psychiatrie, Berlin, Germany
Publications: 
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Health economics, Mental health 2018 English , Real World Data, Retrospective cohort analysis
 
 
Potential Impact of Changes to Basket of Comparator Countries from PMPRB7 to PMPRB12 has on Canadian Product List Prices
Authors: van Doorn-Drennan, J. 1, Minhas, J. 1, Millson, B. 1, McCormick, J. 1
Affiliations: 1 IQVIA, Kanata, ON, Canada
Publications: 
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA
Document Types: 
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/pmprb-ispor-poster-print.pdf
Condition Year Language Analysis type
, Health economics 2018 English
 
 
Dutch health state utilities for infertility and subfertility.
Authors: Krol M, Nap A, Michels RM, Veraart CPWM, Goossens LMA
Affiliations: IQVIA, Netherlands
Publications: 
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Types: , Abstract
Countries: , Netherlands
Condition Year Language Analysis type
, Health economics, Health status & patient reported outcomes 2018 English , Quality of life, Utility analysis
 
 
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.
Authors: López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4.
Affiliations: 1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Publications: 
Infect Agent Cancer. 2018 May 2;13:15.
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29743937
Condition Year Language Analysis type
, Health economics, Immunology and Vaccination, Infectious disease, Oncology 2018 English , Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research
 
 
Análisis coste-utilidad de antivirales de acción directa de segunda generación para la hepatitis C: Una revisión sistemática.
Authors: Puig-Junoy J123, Pascual-Argente N23, Puig-Codina L2, Planellas L4, Solozabal M4.
Affiliations: 1Pompeu Fabra University (UPF), Department of Economics and Business; 2UPF Barcelona School of Management; 3Center for Research in Health and Economics (CRES-UPF); 4IQVIA, Real-World Insights, Barcelona
Publications: 
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/es/
Condition Year Language Analysis type
, Health economics, Infectious disease 2018 Spanish , Clinical setting: hospital, Literature Review, Review, Survey research
 
 
Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review
Authors: Jaume Puig-Junoya,b,c, Natàlia Pascual-Argenteb,c, Lluc Puig-Codinab, Laura Planellasd, Míriam Solozabald
Affiliations: aDepartment of Economics and Business (UPF), Pompeu Fabra University, Barcelona, Spain; bUPF Barcelona School of Management, Pompeu Fabra University, Barcelona, Spain; cUPF Center for Research in Health and Economics (CRES-UPF), Pompeu Fabra University, Barcelona, Spain; dHEOR-RWI, IQVIA Spain
Publications: 
Expert Review of Gastroenterology and Hepatology. Volume 12, 2018 - Issue 12
Document Types: , Article
Countries: , Spain
Abstract: https://www.tandfonline.com/doi/abs/10.1080/17474124.2018.1540929?journalCode=ierh20
Condition Year Language Analysis type
, Health economics, Infectious disease 2018 English , Clinical setting: hospital, Literature Review, Review
 
 
DIFFERENCES AND DECISION DRIVERS IN THE HTA-OUTCOME CATEGORY LOWER BENEFIT BETWEEN IQWIG AND G-BA ASSESSMENT IN THE GERMAN AMNOG PROCESS
Authors: von Hein, Mirko; Peters, Ann-Sophie; Jakovac, Mihael
Affiliations: QuintilesIMS
Publications: 
ISPOR 20th Annual European Congress
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Health economics 2017 English , Public Health
 
 
The cost-effectiveness of IVF treatments Gonal-f® versus HP-hMG in the United Arab Emirates (UAE).
Authors: Mohamed E1, Garg N, Madkour W, Zaheer H, Sayed W, Noah B, Fakih A, Farag T, Wadie G, Jain R, Prasanna R, van Gils C2
Affiliations: 1 Dubai gynaecology & fertility center , UAE 2 Real-World Evidence Solutions QuintilesIMS, Belgium
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom
Document Types: , Abstract
Countries: , UAE
Condition Year Language Analysis type
, Health economics 2017 English , clinical setting: Secondary care, Cost effectiveness
 
 
Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine.
Authors: López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4
Affiliations: 1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
HPV2017 31st International papillomavirus conference, 2017, February 28 – March 4, Cape Town, South Africa
Document Types: , Poster
Countries: , Spain
Abstract: http://hpv2017.org/Documents/HPV%202017%20Final%20Program%20SPIRAL.pdf
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 English , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research
 
 
Análisis de coste-efectividad de empagliflozina en pacientes con diabetes mellitus tipo 2 y enfermedad cardiovascular establecida en España [Analysis of cost-effectiveness of empagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease established in Spain].
Authors: Barrull C1, Massafrets M2, Planellas L1, Perulero N1
Affiliations: 1 RWI, QuintilesIMS, Barcelona 2 Market Access Department, Boehringer Ingelheim, Barcelona
Publications: 
XXXVII Jornadas de Economía de la Salud2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Health economics, Pricing and reimbursement 2017 Spanish , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Cost effectiveness, Cost utility, Literature Review, Patient questionnaire, Randomised controlled trial
 
 
Impacto económico de las enfermedades asociadas al VPH en España: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine].
Authors: López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4
Affiliations: 1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 Spanish , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research
 
 
Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura [Estimating the epidemiological burden of pathologies associated with 9 human papillomavirus genotypes in Spain: Literature review].
Authors: Lopez N1, Viayna E2, Perulero N2, San-Martin M1
Affiliations: 1 Sanofi Pasteur-MSD 2 Quintiles IMS
Publications: 
Vacunas. 2017;18(2):36-42
Document Types: , Article
Countries: , Spain
Abstract: http://www.elsevier.es/es-revista-vacunas-72-avance-resumen-estimacion-carga-epidemiologica-patologias-asociadas-S1576988716300644?referer=buscador
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 Spanish , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review
 
 
Carga epidemiológica y económica de las patologías asociadas al virus del papiloma humano en españa: revisión de la literatura [Epidemiological and economic burden of pathologies associated with human papillomavirus in Spain: literature review].
Authors: Lopez N1, Viayna E2, Perulero N2, San-Martin M1
Affiliations: 1 Sanofi Pasteur-MSD 2 Quintiles IMS
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 Spanish , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review
 
 
Revisión de modelos económicos de coste-efectividad/ coste-utilidad desarrollados con los nuevos agentes antivirales de acción directa para el tratamiento de pacientes con hepatitis c [Review of economic cost-effectiveness / cost-utility models developed with new direct-acting antiviral agents for the treatment of patients with hepatitis C].
Authors: Planellas L1, Pascual N2, Solozabal M1, Rebollo P1, Puig-Junoy J2
Affiliations: 1 QuintilesIMS, RWI, Barcelona, Spain 2 CRES - Universitat Pompeu Fabra, Barcelona, Spain
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/es/#comunicaciones
Condition Year Language Analysis type
, Health economics, Infectious disease 2017 Spanish , Cost effectiveness, Literature Review, Review
 
 
Determinants of the relationship between improved glucose control and modelled health outcomes in type 2 diabetes simulation models.
Authors: Foos V1, Lamotte M1, Altrabsheh E2, Sathananthan A2, McEwan P3
Affiliations: 1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, November 4 - 8, Glasgow, Scotland
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2017 English , Cost effectiveness
 
 
Exploration of run-time requirements in probabilistic sensitivity analysis utilizing a patient level based type 2 diabetes simulation model.
Authors: Foos V1, Lamotte M1, Sathananthan A2, Altrabsheh E2, McEwan P3
Affiliations: 1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2017 English , Cost effectiveness
 
 
BIOSIMILARS AND REFERENCE PRICE GROUPS IN GERMANY
Authors: Eheberg D1, Pointner J1, Antoni B1, Gossmann JA1, Batscheider A1
Affiliations: 1IMS Health, Munich, Germany
Publications: 
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Health economics 2016 English , Pricing & Reimbursement
 
 
USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA
Authors: Jubert H, Kolahi C, Karusisi N, Mitrofan L
Affiliations: IMS Health France
Publications: 
19th ISPOR congress 2016
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition Year Language Analysis type
, Health economics, Oncology 2016 English , Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis
 
 
Estimated budget impact of adopting the affordable care act’s required smoking cessation coverage on united states healthcare payers.
Authors: Baker CL, Ferrufino CP, Bruno M, Kowal S
Affiliations: 
Publications: 
Advances in Therapy. 2016 November; 25:1-5
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://link.springer.com/article/10.1007/s12325-016-0446-y
Condition Year Language Analysis type
, Health economics 2016 English , Budget impact, Cost analysis
 
 
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
Authors: Gizzo S1, Garcia-Velasco JA2, Heiman F3, Ripellino C3, Bühler K4
Affiliations: 1 Department of Woman and Child Health, University of Padua, Padua, Italy 2 Department of Obstetrics and Gynecology, Rey Juan Carlos University Madrid, Madrid, Spain 3 IMS Health Information Solutions Italy Srl, Milan, Italy 4 Centre for Gynaecology, Endocrinology, and Reproductive Medicine, Ulm and Stuttgart, Germany
Publications: 
Int J Womens Health
Document Types: , Manuscript in preparation
Countries: , Germany, Italy, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153281/
Condition Year Language Analysis type
, Health economics, Pregnancy 2016 English , Cost effectiveness
 
 
The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland
Authors: Coles VA, Chapman R, Lanitis T, Carroll SM
Affiliations: Sanofi Pasteur MSD; Evidera
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Health economics, Infectious disease 2016 English , Retrospective database analysis
 
 
Health economic burden that different wound types impose on the UK's National Health Service.
Authors: Guest JF, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D, Vowden K, Vowden P
Affiliations: Catalyst Health Economics Consultants; Faculty of Life Sciences and Medicine, King's College; Bradford Teaching Hospitals NHS Foundation Trust and University of Bradford
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Health economics, Injuries 2016 English , Retrospective database analysis
 
 
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.
Authors: Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F.
Affiliations: 
Publications: 
Rheumatol Ther. 2016 Jun;3(1):53-75.
Document Types: , Article
Countries: , France, Germany, UK, USA
Condition Year Language Analysis type
, Health economics, Health policy, Metabolic Disorders , Public Health 2016 English , Retrospective cohort analysis
 
 
Budget impact of contrast media choice and contrast induced acute kidney injury in high-risk patients undergoing invasive coronary angiography with or without percutaneous coronary intervention from a us hospital perspective.
Authors: Todoran T, Goldfarb S, Pena CS, Ferrufino CP, Kowal S, De Francesco M, Lamotte M, King A
Affiliations: 
Publications: 
International Society for Pharmacoeconomics and Outcomes Research – 21st Annual International Meeting, 2016, May, Washington D.C.
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Health economics, Nephrology 2016 English , Budget impact
 
 
Coste del síndrome del intestino irritable con predominio de estreñimiento en España
Authors: Xavier Cortés1, Montse Roset2, Carmen Barrull2, Carolina Sais3, Anna Raya4
Affiliations:  1 Departamento Médico, Almirall S.A., Barcelona, España; 2 Health Economics & Outcomes Research, IMS Health, Barcelona, España; 3 IASIST, Barcelona, España; 4 Departamento de Marketing, Almirall S.A., Barcelona, España
Publications: 
PharmacoEcon Span Res Artic (2016) 13(1):1-8.
Document Types: , Article
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007/s40277-015-0048-0
Condition Year Language Analysis type
, Clinical practice, Gastrointestinal disorders, Health economics 2016 Spanish , Burden of illness, Clinical setting: Primary care, Cost analysis, Retrospective database analysis
 
 
Impacto presupuestario del uso de un contraste isoosmolar frente a contrastes de baja osmolaridad en pacientes con alto riesgo de nefropatía inducida por contraste en el entorno hospitalario español
Authors: Eduardo Pinar1, José María Hernández2, Josepa Mauri3, Francisco Picó4, Rafael Ruiz5, Ángel Luis de Francisco6, Carmen Barrull7, Emilio Moreno8, Alexis Sampedro8, Felipe Hernández9
Affiliations: 1 Servicio de Hemodinámica, Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, España; 2 Unidad de Hemodinámica, Hospital Virgen de la Victoria, Málaga, España; 3 Unitat d’Hemodinàmica i Cardiologia Intervencionista, Hospital Universitari Germans Trias i Pujol, Barcelona, España; 4 Unidad de Cardiología y Hemodinámica, Hospital Quirón, Murcia, España; 5 Servicio de Hemodinámica e Intervención Endovascular, Hospital Virgen Macarena, Sevilla, España; 6 Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, España; 7 Health Economics & Outcomes Research, IMS Health, Barcelona, España; 8 Departamento Médico, GE Healthcare, Madrid, España; 9 Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, España
Publications: 
PharmacoEcon Span Res Artic (2016) 13(1):17-24.
Document Types: , Article
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007%2Fs40277-015-0049-z
Condition Year Language Analysis type
, Cardiovascular disease, Drug safety, Drug Utlization Study, Health economics 2016 Spanish , Budget impact, Clinical setting: hospital
 
 
The Burden of Ulcerative Colitis and Crohn’s Disease in Spain
Authors: Cortés X1, Fernández-Salazar L2, Márquez L3, Ramos L4, Díaz Rubio C5, Planellas L6, Gasche D6
Affiliations: 1Gastroenterology Section, Internal Medicine of Hospital Universitario de Sagunto. University CEU Cardenal Herrera, Department of Medicine, Valencia; 2Department of Gastroenterology of Hospital Clínico Universitario de Valladolid; Department of Gastroenterology of Hospital del Mar de Barcelona; 4Department of Gastroenterology of Hospital Universitario de Canarias; 5Market Access Department, AbbVie; 6HEOR-RWE, IMS Health
Publications: 
Revista Española de la Economía de Salud (EDS). 2016;11(5):902-913
Document Types: , Article
Countries: , Spain
Abstract: http://www.economiadelasalud.com/Articulo.aspx?i=n5d018
Condition Year Language Analysis type
, Gastrointestinal disorders, Health economics, Immunology and Vaccination 2016 English , Burden of illness, Clinical setting: hospital, Survey research
 
 
Análisis del impacto presupuestario de misoprostol en la maduración cervical e inducción del parto a término
Authors: De la Torre A1, Arjona Berral JA1, Gasche D2, Miñarro C2
Affiliations: 1Unidad de Gestión Clínica de Obstetricia y Ginecología, Hospital Universitario Reina Sofía de Córdoba, Córdoba, España; 2Health Economics & Outcomes Research Real-World Evidence Solutions, IMS Health, S.A., Madrid, España
Publications: 
Pharmacoecon Span Res Artic (2016) 13:141–147
Document Types: 
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007/s40277-016-0060-z
Condition Year Language Analysis type
, Health economics 2016 Spanish , Budget impact, Clinical setting: hospital, Literature Review
 
 
The daily cost of ICU patients: A micro-costing study in 23 French Intensive Care Units.
Authors: Lefrant JY1, Garrigues B2, Pribil C3, Bardoulat I4, Courtial F4, Maurel F4, Bazin JÉ5; CRREA Study Group; AzuRea Group.
Affiliations: 1Division anesthésie réanimation douleur urgences, faculté de médecine, université Montpellier 1, CHU de Nîmes, place du Professeur-Robert-Debré, 30029 Nîmes cedex 9, France. Electronic address: jean.yves.lefrant@chu-nimes.fr. 2Service de réanimation et de surveillances médico-chirurgicales polyvalentes, centre hospitalier du Pays d'Aix, Aix-en-Provence, France. 3Health Outcomes Department, GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France. 4IMS Health, Health Economics and Outcomes Research Department, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 5Service anesthésie réanimation, CHU de Clermont-Ferrand, 1, place Lucile-Aubrac, 63003 Clermont-Ferrand cedex, France.
Publications: 
Anaesthesia Critical Care and Pain Medicine 2015
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25986476
Condition Year Language Analysis type
, Health economics 2015 English , Cost analysis, Economic evaluation, Observational study
 
 
Can different primary care databases produce comparable estimates of burden of disease: results of a study exploring venous leg ulceration
Authors: Petherick ES, Pickett KE & Cullum NA
Affiliations: 
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Health economics 2015 English , Retrospective database analysis
 
 
Clinical outcomes and cost-effectiveness of three alternative compression systems used in the management of venous leg ulcers
Authors: Guest JF, Gerrish A, Ayoub N, Vowden K & Vowden P
Affiliations: Catalyst
Publications: 
J Wound Care 24(7):300-10
Document Types: , Article
Countries: , UK
Abstract: http://www.catalyst-health.co.uk/wound-healing-11.html
Condition Year Language Analysis type
, Health economics 2015 English , Retrospective database analysis
 
 
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.
Authors: Turini M1, Piovesana V1, Ruffo P1, Ripellino C2, Cataldo N2.
Affiliations: 1 Helsinn S A., Lugano, Switzerland, 2 IMS Health Information Solutions Medical Research srl, Milan, Italy.
Publications: 
Drugs Context. 28;4:212285.
Document Types: , Article
Countries: , France, Germany, Italy
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/pdf/dic-4-212285.pdf
Condition Year Language Analysis type
, Health economics, Oncology 2015 English , Survey research
 
 
A cost-effectiveness evaluation comparing biosimilar Bemfola to Gonal-f for the treatment of infertility in an Italian contest.
Authors: Ripellino C1, Visentin E1, Gizzo S2, Bühler K3
Affiliations: 1 IMS Health Information Solutions Medical Research S.r.l, Milan, Italy 2 University of Padua, padua, Italy 3 Centre for Gynaecology, Endocrinology and Reproductive Medicine, Ulm and Stuttgart, Germany
Publications: 
ISPOR Annual European Congress. Milan, Italy.
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Health economics, Pregnancy 2015 English , Cost analysis, Economic evaluation
 
 
Access to New Medicines in Public Drug Plans: Canada and Comparable Countries 2015 Annual Report
Authors: Millson B1, Thiele S1, Zhang Y1, Dobson-Belaire W1, Skinner B2
Affiliations: 1 IMS Health Canada Inc., 16720 Trans-Canada Highway, Kirkland, Quebec H9H 5M3 2 Innovative Medicines Canada, 55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Publications: 
Innovative Medicines Canada Annual Report 2016
Document Types: , Report
Countries: , Canada
Abstract: http://innovativemedicines.ca/wp-content/uploads/2016/05/20160524_Access_to_Medicines_Report_EN_Web.pdf
Condition Year Language Analysis type
, Health economics, Health policy 2015 English , Review
 
 
Health economic burden that wounds impose on the National Health Service in the UK
Authors: Guest JF, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D, Vowden K, Vowden P
Affiliations: Catalyst Health Economics Consultants, Northwood,; Bradford Teaching Hospitals NHS Foundation Trust and University of Bradford
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Health economics, Injuries 2015 English , Retrospective database analysis
 
 
A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK
Authors: Idris I, Gordon J, Tilling C, Vora J
Affiliations: Division of Medical Sciences & Graduate Entry Medicine, University of Nottingham
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes, Health economics 2015 English , Retrospective database analysis
 
 
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
Authors: Gasche D1, Restovic G1, Casado V2, Ramírez-Boix P3, Martínez Lopez J3
Affiliations: 1IMS Health, Barcelona, Spain; 2Mataro Hospital, Mataro, Barcelona, Spain; 3Biogen, Madrid, Spain
Publications: 
Value in Health. Volume 18, Issue 7, November 2015, Page A755
Document Types: , Abstract
Countries: , Spain
Abstract: https://www.sciencedirect.com/science/article/pii/S1098301515050123?via%3Dihub
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Neurological disorders 2015 English , Clinical setting: hospital, Cost effectiveness, Literature Review
 
 
Big data, advanced analytics and the transformation of healthcare delivery: Practical applications in healthcare research
Authors: Keja J1, Incardona F2, Blunt I3, Rigg J1
Affiliations: 1 Real-World Evidence Solutions & HEOR, IMS Health, London, UK 2 Italian Parliamentary Commission on Medical Errors, and Expert Evaluator, European Commission, Rome, Italy 3 The Nutfield Trust, London, UK
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Symposium
Countries: 
Condition Year Language Analysis type
, Health economics 2014 English , Real World Data
 
 
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
Authors: Lebioda A1, Gasche D2, Dippel F-W3, Theobald K4, Plantör S1
Affiliations: 1 IMS Health,Munich, Germany 2 IMS Health, Barcelona, Spain 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 4 Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Publications: 
Health Economics Review, 2014, 4(31)
Document Types: , Article
Countries: , Germany
Abstract: doi:10.1186/s13561-014-0031-5
Condition Year Language Analysis type
, Health economics 2014 English , Methodology
 
 
Evidence-based insights in oncology: The journey is only just beginning
Authors: Ghai C
Affiliations: RWE Solutions & HEOR, IMS Health, New York, USA
Publications: 
AccessPoint, 2014, May; 4(8): 14-20
Document Types: , Article
Countries: , USA
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition Year Language Analysis type
, Health economics, Oncology 2014 English , Real World Evidence
 
 
Patient-reported outcomes assessment
Authors: Crawford B1, Luo N2
Affiliations: 1 Real World Evidence Solutions, Japan & APAC, IMS Health KK, Tokyo, Japan 2 Saw Swee Hock School of Public Health, National University of Singapore, Singapore
Publications: 
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 (short course)
Document Types: , Workshop
Countries: 
Abstract: http://www.ispor.org/Event/Index/44
Condition Year Language Analysis type
, Health economics 2014 English , Real World Evidence
 
 
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.
Authors: Caresano C1, Di Sciascio G2, Fagiolini A3, Maina G4, Perugi G5, Ripellino C6, Vampini C7.
Affiliations: 1 Department of Psychiatry, Lundbeck Italia S.p.A, Milan, Italy, 2 Department of Psychiatry, Policlinico Hospital, Bari, Italy, 3 Department of Molecular Medicine, University of Siena, Siena, Italy, 4 Department of Neurosciences, University of Torino, Turin, Italy, 5 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 6 Institute of Behavioural Sciences ‘‘G. De Lisio’’, Pisa, 7 CSD Medical Research S.R.L., Milan, Italy, 8 Department of Mental Health, Ospedale Civile Maggiore, Verona, Italy.
Publications: 
Adv Ther. 2014 Aug;31(8):873-90. doi: 10.1007/s12325-014-0139-3. Epub 2014 Jul 24
Document Types: , Article
Countries: , Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25055791
Condition Year Language Analysis type
, Health economics, Mental health 2014 English , Cost effectiveness
 
 
GOLD guidelines adherence impact on the NHS budget
Authors: Ripellino C, Guasconi A, Heiman F.
Affiliations: Cegedim Strategic Data Medical Research srl
Publications: 
Farmeconomia. 2014;Vol 15, No 1.
Document Types: , Article
Countries: , Italy
Abstract: http://journals.edizioniseed.it/index.php/FE/article/view/887
Condition Year Language Analysis type
, Health economics, Respiratory disease 2014 English , Economic evaluation, Retrospective database analysis
 
 
Prevalence of smoking among patients treated in NHS hospitals in England in 2010/2011: a national audit.
Authors: Szatkowski L, Murray R, Hubbard R, Agrawal S, Huang Y & Britton J
Affiliations: University of Nottingham Division of Epidemiology and Public Health
Publications: 
Thorax. 2014 Nov 10. pii: thoraxjnl-2014-206285. doi: 10.1136/thoraxjnl-2014-206285
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25385425
Condition Year Language Analysis type
, Health economics, Miscellaneous 2014 English , Epidemiological study, Retrospective database analysis
 
 
Understanding the cost of hereditary angioedema in England.
Authors: Helbert M, Holbrook T, MacCulloch A & Mannan A
Affiliations: Manchester Royal Infirmary Immunology
Publications: 
The European Conference on Rare Diseases and Orphan Products (ECRD); 8th–10th May 2014; Berlin, Germany UK/CIN
Document Types: , Poster
Countries: , UK
Abstract: http://www.rare-diseases.eu/wp-content/uploads/2013/08/27_t1.pdf
Condition Year Language Analysis type
, Dermatology, Health economics 2014 English , Retrospective database analysis
 
 
ASHP national survey of pharmacy practice in hospital settings: Prescribing and transcribing-2013
Authors: Pedersen CA, Schneider PJ, Scheckelhoff DJ.
Affiliations: Confluence Health-Central Washington Hospital, Wenatchee, WA
Publications: 
Am J Health Syst Pharm 2014;71(11):924-942.
Document Types: , Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=ASHP+national+survey+of+pharmacy+practice+in+hospital+settings%3A+Prescribing+and+transcribing-2013.
Condition Year Language Analysis type
, Health economics 2014 English , Real World Evidence
 
 
National Health Spending In 2012: Rate Of Health Spending Growth Remained Low For The Fourth Consecutive Year
Authors: Martin AB, Hartman M, Whittle L, Catlin A, Team the NHEA
Affiliations: National Health Expenditure Accounts Team
Publications: 
Health Aff 2014;33(1):67-77.
Document Types: , Article
Countries: 
Abstract: http://content.healthaffairs.org/content/33/1/67.full
Condition Year Language Analysis type
, Health economics 2014 English , Retrospective cohort analysis
 
 
Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries
Authors: Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5
Affiliations: 
Publications: 
VALUE IN HEALTH 17 ; A684
Document Types: , Abstract
Countries: , Belgium, France, Germany, Italy, Spain
Condition Year Language Analysis type
, Health economics, Immunology and Vaccination, Oncology 2014 English , Cost of illness, Retrospective database analysis
 
 
The economic burden of dasatinib and nilotinib treatment failure in chronic myeloid leukemia (CML) patients: a real-world analysis
Authors: Pokras SM1, Divino V1, Ferrufino C1, Arnold RJA1, Huang H2
Affiliations: 1 IMS Health, Alexandria, USA 2 ARIAD Pharmaceuticals, Cambridge, USA
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International Meeting. May 20, 2013
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Health economics 2013 English , Economic evaluation
 
 
Powering a new age of outcomes research
Authors: Keja J1, Bonzani I2
Affiliations: 1IMS Health, The Netherlands, 2IMS Health, London, UK
Publications: 
AccessPoint, May 2013; Vol 3(6); 18-22
Document Types: , Article
Countries: 
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub
Condition Year Language Analysis type
, Health economics, Miscellaneous 2013 English , Real World Evidence
 
 
Evolution of HTA and pharmaecoeconomic analyses in Latin America
Authors: Arnold R1
Affiliations: 1IMS Health, New York, USA
Publications: 
AccessPoint, May 2013; Vol 3(6); 44-49
Document Types: , Article
Countries: , Latin America
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub
Condition Year Language Analysis type
, Health economics, Miscellaneous 2013 English , Methodology
 
 
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy.
Authors: Mencacci C1, Aguglia E2, Biggio G3, Cappellari L4, Di Sciascio G5, Fagiolini A6, Maina G7, Tortorella A8, Katz P9, Ripellino C9.
Affiliations: 1 Department of Mental Health Fatebenefratelli Hospital, Milan, Italy, 2 Professor of Psychiatry, Department of Clinical and Molecular Biomedicine, University of Catania, 3 Department of Experimental Biology and Center of Excellence for the Neurobiology of Drug Dependence, University of Cagliari, Italy, 4 Department of Mental Health, Camposampiero Hospital, Padova, Italy, 5 Department of Psychiatry-Policlinico Hospital-Bari-Italy, 6 Department of Molecular Medicine University of Siena and Department of Mental Health, University of Siena Medical Center, 7 Department of Neurosciences, University of Torino, Italy, 8 Department of Mental Health, University of Naples, SUN, Italy, 9 CSD Medical Research Srl, Milan, Italy
Publications: 
Advances in Therapy. July 2013, Volume 30, Issue 7, pp 697-712.
Document Types: , Article
Countries: , Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23929174
Condition Year Language Analysis type
, Health economics, Mental health 2013 English , Cost utility, Economic evaluation, Prospective study, Quality of life
 
 
Analisi farmaco-economica sui costi e la qualità di vita dei pazienti affetti da Disturbo Depressivo Maggiore (DDM) trattati con cura antidepressiva in Italia_ Pharmaco-economic analysis on the costs and quality of life of patients with Major Depressive Disorder (MDD) receiving antidepressant treatment in Italy.
Authors: Pegoraro V, Guasconi A, Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Ripellino C.
Affiliations: Center of Molecular and Genetic Epidemiology, Department of Environmental and Occupational Health, Università degli Studi di Milano and IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Publications: 
Congresso Nazionale SIHTA 2013, Bari
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Health economics, Mental health, Neurological disorders 2013 Italian , Cost analysis, Economic evaluation, Quality of life, Retrospective database analysis
 
 
C-QUALITY: Cost and Quality-of-Life Pharmacoeconomic Analysis of Antidepressants in Major Depressive Disorder in Italy.
Authors: Ripellino C, Heiman F, Katz P.
Affiliations: CSD Medical Research Milano
Publications: 
ISPOR Annual European Congress. 2013, Dublin
Value in health
Document Types: , Poster
Countries: , Italy
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03318-4/abstract
Condition Year Language Analysis type
, Health economics, Mental health 2013 English , Cost analysis, Quality of life
 
 
Audit of the effect of relative age on morbidity among children in The Health Improvement Network (THIN) UK data.
Authors: Johnson M, Mook P, Thompson M, Bourke A.
Affiliations: Cegedim
Publications: 
29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Montreal, Canada
Document Types: , Poster
Countries: , UK
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf
Condition Year Language Analysis type
, Health economics, Miscellaneous 2013 English , Retrospective database analysis
 
 
An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
Authors: Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C & Bate A
Affiliations: Cegedim
Publications: 
Drug Saf. 2013 Feb;36(2):119-34. doi: 10.1007/s40264-012-0009-3.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23329543
Condition Year Language Analysis type
, Health economics, Methodology 2013 English , Retrospective database analysis
 
 
Exploring the cost and burden of illness of hereditary angioedema in the UK.
Authors: Helbert M, Holbrook T, Drogon E & Mannan A
Affiliations: Adelphi
Publications: 
UK PIN Liverpool Liverpool, UK 2013
Document Types: , Poster
Countries: , UK
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf
Condition Year Language Analysis type
, Dermatology, Health economics 2013 English , Retrospective database analysis
 
 
Risk identification in Healthcare Records: comparison to epidemiological studies.
Authors: Edwards IR1, Karimi G1, Bergvall T1, Caster O1, Asiimwe A2, Star K1, Bhayat F3, Soriano-Gabarro M4, Thakrar B5, Thompson M6, Bate A7 & Norén GN1
Affiliations: 1 Uppsala Monitoring Centre, Uppsala, Sweden. 2 Eli Lilly UK, Surrey, United Kingdom. 3 Takeda (TGRD), London, United Kingdom. 4 Bayer Pharma AG, Berlin, Germany. 5 F Hoffmann-La Roche, Basel, Switzerland, 6 Cegedim Strategic Data Medical Research Ltd, London, United Kingdom. 7 Pfizer UK, Surrey, United Kingdom 6. Cegedim
Publications: 
29th International Conference on Pharma, coepidemiology and Therapeutic Risk Management (ICPE), Montreal, Canada
Document Types: , Poster
Countries: , UK
Abstract: http://www.imi-protect.eu/documents/IREdwardsetalRiskidentificationinHealthcareRecordscomparisontoepidemiologicalstudiesICPEAug2.pdf
Condition Year Language Analysis type
, Health economics, Methodology 2013 English , Retrospective database analysis
 
 
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia.
Authors: Mencacci C1, Aguglia E2, Biggio G3, Cappellari L4, Di Sciascio G5, Fagiolini A6, Maina G7, Tortorella A8, Katz P9, Ripellino C9.
Affiliations: 1 Department of Mental Health, Fatebenefratelli Hospital, Milan 2 Department of Clinical and Molecular Biomedicine, University of Catania, Catania 3 Department of Experimental Biology and Center of Excellence for the Neurobiology of Drug Dependence, University of Cagliari, Calgiari 4 Department of Mental Health, Camposampiero Hospital, Padova 5 Department of Psychiatry, Policlinico Hospital, Bari 6 Department of Molecular Medicine, University of Siena and Department of Mental Health, University of Siena Medical Center, Siena 7 Department of Neurosciences, University of Torino, Torino 8 Department of Mental Health, University of Naples SUN, Naples 9 CSD Medical Research Srl, Milan, Italy
Publications: 
Clinicoecon Outcomes Res. 5:611-21
Document Types: , Article
Countries: , Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=C-QUALITY%3A+cost+and+quality-of-life+pharmacoeconomic+analysis+of+antidepressants+used+in+major+depressive+disorder+in+the+regional+Italian+settings+of+Veneto+and+Sardinia.
Condition Year Language Analysis type
, Health economics, Mental health 2013 English , Cost utility, Economic evaluation, Quality of life
 
 
Less spending on prescription drug promotion
Authors: xxx
Affiliations: Massachusetts Institute of Technology
Publications: 
PharmacoEcon Outcomes News 2013;675(1):8-8
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Health economics 2013 English , Public Health
 
 
AstraZeneca's Real-World Bet
Authors: Upton J.
Affiliations: Pharmaceutical Executive
Publications: 
Pharmaceutical Executive
Document Types: , Article
Countries: , UK
Abstract: http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=761326
Condition Year Language Analysis type
, Health economics 2012 English , Review
 
 
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.
Authors: Ikenberg R1, Hertel N2, Moore RA3, Obradovic M4, Baxter G5, Conway P5, Liedgens H4
Affiliations: 1 IMS Health GmbH & Co, Munich, Germany, 2 IMS Health, London, UK, 3 Oxford University, Oxford, UK, 4 Grünenthal GmbH, Aachen, Germany, 5 Grünenthal Ltd, Stokenchurch, UK
Publications: 
Journal of Medical Economics, 2012, 15(4): 1-13
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22364286
Condition Year Language Analysis type
, Health economics 2012 English , Cost effectiveness
 
 
Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs
Authors: Obradovic M1, Ikenberg R2, Hertel N3, Antoñanzas F4, Gálvez R5, Liedgens H1
Affiliations: 1 Grünenthal GmbH, Aachen, Germany 2 IMS Health Economics and Outcomes Research, Munich, Germany 3 IMS Health Economics and Outcomes Research, London, UK 4 Department of Economics and Business, University of La Rioja, Logroño, Spain 5 Pain and Palliative Care Unit, University Hospital Virgen de las Nieves, Granada, Spain
Publications: 
Clinical Therapeutics/Volume 34, Number 4, 2012
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2012 English , Cost effectiveness
 
 
Learning from global trends in HTA
Authors: Nelson M1, Lee Chan W2
Affiliations: 1IMS Health, Alexandria, USA, 2IMS Health, San Francisco, USA
Publications: 
AccessPoint, Nov 2012; Vol 3(5); 42-49
Document Types: , Article
Countries: 
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf
Condition Year Language Analysis type
, Health economics 2012 English
 
 
Adapting global health economic models to emerging markets
Authors: Arnold R1
Affiliations: 1IMS Health, New York, USA
Publications: 
AccessPoint, Nov 2012; Vol 3(5); 30-36
Document Types: , Article
Countries: 
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf
Condition Year Language Analysis type
, Health economics 2012 English
 
 
Health economics analysis of pegfilgrastim in the prophylaxis of febrile neutropenia (FN) in Italy.
Authors: G. Rosti 1, M. Lebboroni 1, A. Cerchiari 2, P. Katz 3
Affiliations: 1 Ospedale Regionale Azienda Unità Locale Socio Sanitaria n°9 di Treviso, Oncologia Medica, Treviso, Italy 2 Amgen Dompè SpA, Health Economics, Milano, Italy 3 CSD Medical Research S.r.l, Pharmacoepidemiology & Health Economics, Milano, Italy
Publications: 
17th Congress of European Association of Hospital Pharmacists,
Document Types: , Poster
Countries: , Italy
Abstract: http://ejhp.bmj.com/content/19/2/172.2
Condition Year Language Analysis type
, Health economics, Hematology 2012 English , Budget impact
 
 
COST-EFFECTIVENESS ANALYSIS OF DEPRESSION IN ITALY.
Authors: Katz P1, Mencacci C, Di Sciascio G, Ripellino C, Heiman F
Affiliations: 1CSD Medical Research Milan
Publications: 
15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Berlin, Germany
Document Types: , Poster
Countries: , Italy
Abstract: http://www.ispor.org/E6E2C004-9FF1-4F7E-897E-BC292C74DF07/FinalDownload/DownloadId-24780E6AB48005853A097D13F4256DC1/E6E2C004-9FF1-4F7E-897E-BC292C74DF07/publications/value/valueinhealth_volume15_issue7.pdf
Condition Year Language Analysis type
, Health economics, Mental health, Neurological disorders 2012 English , Cost effectiveness
 
 
Changing paradigms in the long‐term care market
Authors: Laryssa Wozniak, Mahmud Hassan, Dale Benner.
Affiliations: Confluence Health-Central Washington Hospital, Wenatchee, WA
Publications: 
Intl J of Pharm & Health Mrkt 2012;6(3):267-278.
Document Types: , Article
Countries: 
Abstract: http://www.emeraldinsight.com/doi/abs/10.1108/17506121211259421
Condition Year Language Analysis type
, Health economics 2012 English , Real World Evidence
 
 
The cost per day of intensive care units (ICU) in France : the CRRéa study.
Authors: Garrigues B1, Lefrant JY2, Bazin JE3, Bardoulat I4, Tagdichti K4, Courtial F4, Maurel F4, Pribil C5
Affiliations: 1 CH du Pays d'Aix, Aix-en6provence, France 2 CHU de Nîmes , Nîmes, France 3 CHRU de Clermont-Ferrand, Clermont-Ferrand, France 4 IMS Health, Puteaux, France 5 GSK France, Marly-le-Roi, France.
Publications: 
Abstract - Presentation PHP75 for the 14th European congress of Ispor 2011
Document Types: , Abstract, Poster
Countries: , France
Condition Year Language Analysis type
, Health economics 2011 English , Cost analysis, Economic evaluation, Prospective study
 
 
Resource utilisation related to catheter-associated urinary tract infections in Swedish spinal injury patients
Authors: Bruce S1, Löfroth E1, Knutsson B2, Börstell T2, Myrén KJ1.
Affiliations: 1 IMS Consulting Group, Stockholm, Sweden. 2 AstraTech, Mölndal, Sweden.
Publications: 
ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain
Document Types: , Poster
Countries: , Sweden
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx
Condition Year Language Analysis type
, Health economics, Infectious disease, Urology 2011 English , Burden of illness, Cost analysis, Epidemiological study, Retrospective database analysis
 
 
Resource utilisation related to urinary tract infections in Swedish self-catheterisation patients
Authors: Löfroth E1, Bruce S1, Knutsson B2, Börstell T2, Myrén KJ1.
Affiliations: 1 IMS Consulting Group, Stockholm, Sweden. 2 AstraTech, Mölndal, Sweden.
Publications: 
ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Health economics, Infectious disease, Urology 2011 English , Burden of illness, Cost analysis, Epidemiological study, Retrospective database analysis
 
 
Beyond Real-World Evidence
Authors: Badia X1, Bergström R2, Keja J3
Affiliations: 1 IMS Consulting Group, Barcelona, Spain; 2 EFPIA, Brussels, Belgium; 3 IMS Consulting Group, London, UK
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Symposium
Countries: 
Condition Year Language Analysis type
, Health economics 2011 English , Prospective study
 
 
Analisi di budget impact sull’utilizzo di pegfilgrastim nella profilassi della neutropenia febbrile in Italia.
Authors: Rosti G1, Lebboroni M1, Cerchiari A2, Katz P3.
Affiliations: 1 Oncologia Medica, Ospedale Regionale, Azienda Unità Locale Socio Sanitaria n°9 di Treviso, 2 Amgen Dompè SpA, Italia, 3 CSD Medical Research Srl, Italia
Publications: 
Farmeconomia e percorsi terapeutici. 12(3). 119-127.
Document Types: , Article
Countries: , Italy
Condition Year Language Analysis type
, Health economics, Oncology 2011 Italian , Budget impact
 
 
Commercial importation of prescription drugs in the United States: short-run implications
Authors: Danzon PM, Johnson SJ, Long G, Furukawa MF
Affiliations: University of Rochester Medical Center, Rochester
Publications: 
J Health Polit Policy Law 2011;36(2):295-316.
Document Types: , Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Commercial+importation+of+prescription+drugs+in+the+United+States%3A+short-run+implications.
Condition Year Language Analysis type
, Health economics 2011 English , Economic evaluation
 
 
Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates
Authors: Blak BT, Thompson M, Dattani H & Bourke A
Affiliations: Cegedim Strategic Data Medical Research Ltd, London, UK.
Publications: 
Inform Prim Care . 2011;19(4):251-5. doi: 10.14236/jhi.v19i4.820.
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/22828580/
Condition Year Language Analysis type
, Database Validity and methodology, Health economics 2011 English , Database Study
 
 
Impacto de la introducción de alitretinoína oral en los costes del eczema de las manos severo de origen profesional desde la perspectiva de las Mutuas de Accidentes de Trabajo y Enfermedades Profesionales en España.
Authors: Manuel Mascaró J, Quero Nasarre I, Lindner L, Prior M, Oliver J, Halbach R.
Affiliations: Manuel Mascaró J1, Quero Nasarre I2, Lindner L3, Prior M3, Oliver J4, Halbach R4. 1Servicio de Dermatología, Hospital Clínic de Barcelona. 2Servicio de Dermatología. MAZ de Zaragoza. 3IMS Health. 4Basilea Pharmaceuticals Iberia, S. L.
Publications: 
Rev. SEMST 2010; 5(1): 9-18
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Abstract: http://dialnet.unirioja.es/servlet/articulo?codigo=3161177
Condition Year Language Analysis type
, Dermatology, Health economics 2010 Spanish , Cost analysis, Cost consequence
 
 
Agreements with pharmaceutical industry: “Paying pay for results”
Authors: Badia X, Prior M.
Affiliations: 
Publications: 
Farm Hosp.2010;34(2):53–55.
Document Types: , Article
Countries: , Spain
Abstract: http://www.sefh.es/fh/105_121v34n02pddf001.pdf
Condition Year Language Analysis type
, Health economics 2010 Spanish , Cost effectiveness
 
 
Regionalization of Market research. Why should it be evidence-based.
Authors: Badia X, Sabater J.
Affiliations: 
Publications: 
PM Farma 2010;XVII(105):54-55.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2010 Spanish , Cost analysis
 
 
Healthcare utilisation after platelet aggregation inhibitors.
Authors: Löfroth E, Myrén KJ, Bruce S.
Affiliations: IMS Health, Stockholm, Sweden.
Publications: 
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: , Poster
Countries: , Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters2.aspx
Condition Year Language Analysis type
, Health economics 2010 English , Retrospective database analysis
 
 
Prevalence of affective disorders in South-West region of Sweden.
Authors: Löfroth E, Myrén KJ, Bruce S, Dahlberg E.
Affiliations: IMS Health, Stockholm, Sweden.
Publications: 
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx
Condition Year Language Analysis type
, Health economics 2010 English , Retrospective database analysis
 
 
Healthcare utilisation of major depressive disorder patients.
Authors: Myrén KJ, Löfroth E, Dahlberg E.
Affiliations: IMS Health, Stockholm, Sweden.
Publications: 
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Health economics 2010 English , Retrospective database analysis
 
 
Cost impact of initiating pregabalin treatment in Swedish patients with generalized anxiety disorder.
Authors: Löfroth E1, Myrén KJ1, Sandelin R2.
Affiliations: 1. IMS Health, Stockholm, Sweden. 2. Pfizer AB, Sollentuna, Sweden.
Publications: 
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: , Poster
Countries: , Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx
Condition Year Language Analysis type
, Health economics 2010 English , Retrospective database analysis
 
 
Cost impact from initiating pregabalin treatment in patients with refractory neuropathic pain.
Authors: Myrén KJ1, Löfroth E1, Sandelin R2.
Affiliations: 1. IMS Health, Stockholm, Sweden. 2. Pfizer AB, Sollentuna, Sweden.
Publications: 
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: , Poster
Countries: , Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx
Condition Year Language Analysis type
, Health economics 2010 English , Retrospective database analysis
 
 
Assessment of the workload real time dedicated to each patient in intensive care units (ICU): preliminary results of the CRREA study
Authors: Garrigues B (1), Lefrant JY (2), Bazin JE (3), Probil C (4), Maurel F(5)
Affiliations: 1. CH du Pays d'Aix, Aix en Provence, France 2. CHU de Nïmes, Nïmes, France 3. CHRU de Clermont-Ferrand, Clermont-Ferrand, France 4. GSK France, Marly-Le-Roi, France 5. IMS Health, Puteaux, France
Publications: 
ISPOR 13th Annula European Congress to be held 6-9 November 2010 at the Prague Congress Centre in Prague, Czech Republic
Document Types: , Abstract, Poster
Countries: , France
Condition Year Language Analysis type
, Health economics 2010 English , Clinical setting: hospital, Cost analysis, Observational study, Prospective study
 
 
Quel est le temps réellement consacré à chaque patient en service de réanimation? résultats préliminaires de l'étude CRRéA
Authors: Lefrant JY (1), Bazin JE (2), Pribil C (3), Maurel F (4), Gariigues B (5)
Affiliations: 1. CHU de Nîmes, Nîmes, France 2. CHRU de Clermont-Ferrand, Clermont Ferrand, France 3. GSK France, Marly-Le-Roi, France 4. IMS Health, Puteaux, France 5. CH du pays d’Aix, Aix-en-Provence, France
Publications: 
SFAR 2010, Congrès national d'anesthésie et de réanimation du 22 au 25 septembre 2010 - session Médecine d'urgence 2
Document Types: , Abstract, Oral presentation
Countries: , France
Condition Year Language Analysis type
, Health economics 2010 French , Cost analysis, Observational study
 
 
Cost-effectiveness of tapentadol prolonged-release (PR) compared to oxycodone and morphine in patients with chronic moderate to severe non-cancer pain in Sweden
Authors: Hertel N1, Ikenberg R1, Fricke FU12, Liedgens H3
Affiliations: 1IMS Health, Nuremberg, Germany 2Georg Simon Ohm University of Applied Sciences, Nuremberg, Germany 3Gruenenthal GmbH, Aachen, Germany
Publications: 
ISPOR November 6-9, 2010 Prague, Czech Republic
Document Types: , Abstract
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, Health economics, Musculoskeletal disease 2010 English , Cost benefit
 
 
A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit*
Authors: Dasta JF, Kane-Gill SL, Pencina M, et al
Affiliations: University of Miami, Florida
Publications: 
Critical Care Medicine 2010;38(2):497-503
Document Types: , Abstract
Countries: 
Abstract: http://journals.lww.com/ccmjournal/Abstract/2010/02000/A_cost_minimization_analysis_of_dexmedetomidine.20.aspx
Condition Year Language Analysis type
, Health economics 2010 English , Cost minimization
 
 
Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
Authors: Trusheim MR, Aitken ML, Berndt ER.
Affiliations: Massachusetts Institute of Technology
Publications: 
Forum for Health Economics & Policy. Jul 2010; 13(1) 1558-9544.
Document Types: , Book
Countries: 
Abstract: http://www.degruyter.com/dg/viewarticle/j$002ffhep.2010.13.1$002ffhep.2010.13.1.1200$002ffhep.2010.13.1.1200.xml
Condition Year Language Analysis type
, Health economics 2010 English , Public Health
 
 
Assessment of the workload real time dedicated to each patient in intensive care units (icu): preliminary results of the crréa study.
Authors: Garrigues B1, Lefrant JY2, Bazin JE3, Pribil C4, Maurel F5
Affiliations: 1 CH du pays d’Aix, Aix-en-Provence, France 2 CHU de Nîmes, Nîmes, France 3 CHRU de Clermont-Ferrand, Clermont Ferrand, France 4 GSK France, Marly-Le-Roi, France 5 IMS Health, Puteaux, France
Publications: 
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Health economics 2010 English , Clinical setting: hospital, Cost effectiveness, Observational study, Prospective study
 
 
Using Early Economic Modelling to inform strategic pricing and clinical study design
Authors: Lloyd A1, Chambers M2, Caputo J1
Affiliations: 1 IMS Health, London, UK 2 GlaxoSmithKline, Uxbridge, UK
Publications: 
ISPOR 12th Annual European Congress, Paris France 24-27th October 2009
Document Types: , Workshop
Countries: , UK
Condition Year Language Analysis type
, Health economics 2009 English , Workshop
 
 
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie - eine „real life“- Analyse der Versorgungssituation in Deutschland [Consumption of erythropoietin-stimulating factors in the renal anaemia therapy - a "real life"-analysis of the German medical treatment situation]
Authors: Schöffski O1, Müller H-J2, Kostev K3, Claus V4
Affiliations: 1 University Erlangen-Nuremberg, Nuremberg, Germany 2 Med. Klinik III Klinikum Fulda gAG, Fulda, Germany 3 IMS Health, Frankfurt, Germany 4 IMS Health, Munich, Germany
Publications: 
Congress for nephrology, Göttingen, Germany, 26-29 September 2009
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Health economics, Hematology, Nephrology 2009 German , Retrospective database analysis
 
 
[Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol] Genotyping in patients in treatment with acenocumarol cost-effectiveness.
Authors: Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L
Affiliations: Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1Health Economics & Outcomes Research - IMS Health; 2Servicio de Hemoterapia y Hemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A
Publications: 
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics, Hematology 2009 Spanish , Cost effectiveness
 
 
Publication trends of budget impact analyses over the past six years.
Authors: Pathak P, Kowal-Podmore S, Munakata J
Affiliations: 
Publications: 
ISPOR 14th International Meeting
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Health economics 2009 English , Literature Review
 
 
Complex Attention-Deficit/Hyperactivity Disorder: Patient Characteristics, Health Care Utilization And Costs In A Retrospective Observational Claims Study
Authors: Hess G1, Sasane R2, Hill J1, Hodgkins P2, Shah MR1
Affiliations: 1IMS Health, former SDI Health, Plymouth Meeting, PA, USA, 2Shire Pharmaceuticals, Wayne, PA, USA
Publications: 
Value in Health Volume 12, Issue 7 , Page A361, October 2009
Document Types: , Article
Countries: 
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)74773-2
Condition Year Language Analysis type
, Health economics, Pediatrics, Pricing and reimbursement 2009 English , Cost analysis, Cost utility, Observational study
 
 
The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia.
Authors: Polsky D1, Eremina D2, Hess G12, Hill J2, Hulnick S2, Roumm A2, Whyte JL3, Kallich J3
Affiliations: 1University of Pennsylvania, Philadelphia, PA, USA, 2IMS Health (Former SDI Health),Plymouth Meeting, PA, USA, 3Amgen Inc., Thousand Oaks, California, USA
Publications: 
Pharmacoeconomics. 2009;27(9):755-65
Document Types: , Article
Countries: 
Abstract: http://link.springer.com/article/10.2165%2F11313860-000000000-00000
Condition Year Language Analysis type
, Health economics, Hematology 2009 English , Cost analysis, Cost effectiveness, Quality of life
 
 
Cost-effectiveness analysis of smoking cessation pharmacotherapies in Australia
Authors: Bhatti T, Makino K, Guarnieri C, Gordois A, Cotter T, Perez D, Bishop J, Glass P
Affiliations: 
Publications: 
ISPOR 3rd Asia-Pacific Conference, Seoul, Korea, September 2008
Document Types: , Poster
Countries: , Australia
Condition Year Language Analysis type
, Health economics 2008 English , Cost effectiveness
 
 
Eficiency and drugs: Review of Guidelines for Economic Evaluation
Authors: Del Llano J, Pinto JL, Abellán JM, Barbieri M, Polanco C
Affiliations: 
Publications: 
La Cuarta Garantía. Sanofi-aventis, Barcelona (2008). ISBN: 978-84-691-2988-3
Document Types: , Book
Countries: 
Condition Year Language Analysis type
, Health economics 2008 Spanish , Economic evaluation
 
 
Modelo de impacto presupuestario de la administración de darbepoetina alfa cada 3 semanas comparado con la administración de epoetina alfa y epoetina beta 3 veces por semana y semanalmente en pacientes con anemia inducida por quimioterapia [Budget impact model of darbepoetin alfa administered once every three weeks relative to epoetin alfa and beta administered three times per week or weekly in patients with chemotherapy induced anaemia]
Authors: Pérez-Alcántara F1, Badia Llach X1, Riera Febrer M1, Vieta Salomó A1, Arocho R2
Affiliations: 1IMSHealth®; 2Amgen S.A.
Publications: 
Revista Española de Economía de la Salud 2008; 7(1):41-48
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Cost consequence
 
 
Economic assessment of controlled-release Oxycodone for the treatment of chronic pain
Authors: Gálvez Mateos R, Camps Herrero C, Lara Suriñach N, Polanco Sánchez C
Affiliations: 
Publications: 
Rev Esp Econ Salud 2008;7(4):157-164
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Economic evaluation
 
 
Impacto sociosanitario en pacientes con enfermedades raras (estudio ERES) [Sociosanitary impact on patients with rare diseases (ERES study)]
Authors: Avellaneda Fernández A1,2, Layola M3, Izquierdo Martínez M1,4, Guilera M3, Badia Llach X3, Ramón JR1
Affiliations: 1Instituto de Investigación de Enfermedades Raras (IIER). Instituto de Salud Carlos III. Madrid. 2Centro Sanitario Los Cármenes. Comunidad de Madrid. Madrid. 3Grupo Health Outcomes Research Europe (Grupo HOR-Europe). 4Servicio de Análisis e Intervención en Salud Pública. Dirección General de Salud Pública y Alimentación. Comunidad de Madrid. Madrid. España.
Publications: 
Medicina Clinica 2007;129(17):646-51
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Market impact
 
 
Global and Spanish Pharmaceuticals market trends
Authors: Prior M
Affiliations: 
Publications: 
The 28th days on Health economics: economics, behaviour and health, Salamanca 28-30 may 2008
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish
 
 
Retos en la evaluación económica de productos oncológicos [Challenges in economic evaluation of oncological products]
Authors: Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
Summer School of pharmacoeconomics: Economic evaluation of health intervention 2008 May 18-19, Granada, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Economic evaluation
 
 
Regional market access inequalities for new oncology drugs in Spain
Authors: Vieta A1, Gimenez E1, Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 English
 
 
Pharmabetriebslehre [Business operations in the pharmaceutical industry]
Authors: Schöffski O1, Fricke F-U2, Guminski W3 (ed.)
Affiliations: 1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany 3 TNS Healthcare, Munich, Germany
Publications: 
Berlin-Heidelberg, Springer, Second edition
Document Types: , Book
Countries: 
Condition Year Language Analysis type
, Health economics 2008 German , Methodology
 
 
Die pharmazeutische Industrie und der Arzneimittelmarkt [Pharmaceutical industry and drug market]
Authors: Fricke F-U1, Schöffski O2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 University Erlangen-Nuremberg, Germany
Publications: 
Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 23-46
Document Types: , Book chapter
Countries: 
Condition Year Language Analysis type
, Health economics 2008 German , Methodology
 
 
Pharmacotherapy evaluation: Drugs that assist smoking cessation
Authors: Perez D, Cotter T, Makino K, Bhatti T, Gordois A, Guarnieri C, Lewis S, Glass P, Bishop J
Affiliations: 
Publications: 
Sydney: Cancer Institute NSW
Document Types: , Report
Countries: , Australia
Condition Year Language Analysis type
, Health economics 2008 English , Economic evaluation
 
 
Health economics review of bowel cancer in Australia
Authors: Bishop J, Glass P, Tracey E, Hardy M, Warner K, Makino K, Gordois A, Wilson J, Guarnieri C, Feng J, Sartori L
Affiliations: 
Publications: 
NSW Cancer Institute, Sydney
Document Types: , Review
Countries: , Australia
Condition Year Language Analysis type
, Health economics 2008 English , Cost effectiveness
 
 
Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
Authors: Hass B1, Lungershausen J1, Hertel N1, Kotowa W1, Poulsen Nautrup B2, Liedgens H3
Affiliations: 1 IMS Health, Nuremberg, Germany 2 EAH-Consulting, Juelich, Germany 3 Gruenenthal GmbH, Aachen, Germany
Publications: 
The European journal of health economics, 21. Dezember 2008
Document Types: , Online article
Countries: , Germany
Condition Year Language Analysis type
, Health economics, Musculoskeletal disease 2008 English , Cost effectiveness
 
 
Estimated costs associated with different fracture risks related to opioid treatment in Germany
Authors: Kotowa W1, Völkl M1, Hass B1, Poulsen Nautrup B2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 EAH Consulting, Juelich, Northrhine Westf
Publications: 
ISPOR 12th Annual International Meeting 2007, May 19-23, Arlington, VA, USA
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition Year Language Analysis type
, Health economics 2007 English , Cost effectiveness
 
 
From evidence-based medicine to health outcomes research:an approach to reality
Authors: Badia X, Lizán L.
Affiliations: 
Publications: 
Rev Esp Econ Salud 2007;6(1):42-44
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 Spanish , Methodology
 
 
Economic evaluations in pricing and reimbursement process of pharmaceutical products in Europe
Authors: Vieta A, Lara N, Badia X
Affiliations: 
Publications: 
XXVII Jornadas de Economía de la Salud (AES). La Coruña 6-8 June
Document Types: , Oral presentation
Countries: , Europe
Condition Year Language Analysis type
, Health economics 2007 Spanish , Pricing & Reimbursement
 
 
A cross-sectional validation of the mini-HIV questionnaire
Authors: Pedrol E, Ortega E, Sanz J, Suárez-Lozano I, Perulero N, García Pulgar MS, Escayola R
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 English , Quality of life
 
 
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies
Authors: Tunis SL1, Pelletier EM2, St. Charles M1, McEwan P3.
Affiliations: 1IMS Health, Noblesville, IN, USA, 2IMS Health, Watertown, MA, USA, 3Cardiff Medicentre, University Hospital of Wales, Cardiff, UK
Publications: 
ISPOR 10th Annual European Meeting, 2007, October, Dublin, Ireland
Document Types: , Workshop
Countries: , USA
Condition Year Language Analysis type
, Health economics, Methodology 2007 English , Methodology, Retrospective database analysis
 
 
European databases and retrospective database analysis
Authors: Elise Pelletier; Erik Spaepen
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: , Europe
Condition Year Language Analysis type
, Health economics 2007 English , Review
 
 
Der gesundheitspolitische Nutzen von Evaluationsstudien [The health-political benefit of evaluation-surveys]
Authors: Fricke FU
Affiliations: IMS Health, Nuremberg, Germany
Publications: 
Schoeffski O, v. d. Schulenburg JM (ed.): Gesundheitsökonomische Evaluationen, 3. vollständig überarbeitete Auflage, Berlin-Heidelberg, Springer, 2007, 509-534
Document Types: , Book chapter
Countries: 
Condition Year Language Analysis type
, Health economics 2007 German , Pricing & Reimbursement
 
 
Field Research
Authors: Pirk O1, Claes C2, Schöffski O2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 Forschungsstelle für Gesundheitsökonomie und Gesundheitssystemforschung, Universität Hannover
Publications: 
Schoeffski O, v. d. Schulenburg JM (ed.): Gesundheitsökonomische Evaluationen, 3. vollständig überarbeitet Auflage, Berlin-Heidelberg, Springer, 2007, 201-260
Document Types: , Book chapter
Countries: 
Condition Year Language Analysis type
, Health economics 2007 German
 
 
The spectrum OF health care costs associated WITH herpes zoster: acute pain vs. postherpetic neuralgia
Authors: Hawkins K, White R, Dworkin R, O'connor A, Baser O
Affiliations: 
Publications: 
ISPOR 12th Annual International Meeting, May 19-23, 2007
Document Types: , Poster
Countries: , USA
Abstract: http://www.ispor.org/research_study_digest/details.asp
Condition Year Language Analysis type
, Health economics 2007 English
 
 
Patient transfer decrease and health insurance costs savings associated with telemedicine consultation. Example of the telemedicine network of “midi-pyrénées” (RTR)
Authors: LARENG L; SALVODELLI M; BILLON S; BOURGUIGNON S; LECLERCQ C.
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: 
Condition Year Language Analysis type
, Health economics 2007 English
 
 
Conjoint analysis a technique to develop a questionnaire of treatment preferences in patients with lung cancer
Authors: Perulero N, Cardenal F, Garcia R, Juan O, Vázquez S, Barneto I, Varela C
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 English , Quality of life
 
 
Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
Authors: Plesnila Frank C, Rottenkolber D, Berger K
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: , Germany
Condition Year Language Analysis type
, Health economics 2007 English
 
 
Evaluación económica de medicamentos biotecnológicos: retos y oportunidades [Economic Evaluation of biotechnological drugs: challenge and opportunities]
Authors: Badia Llach X, Polanco Sánchez C
Affiliations: 
Publications: 
Rev Esp Econ Salud 2007;6(6):352-7
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 Spanish , Economic evaluation
 
 
Is the regulation of the pharmaceutical market justified?
Authors: Vieta A
Affiliations: 
Publications: 
Rev Esp Econ Salud 2007;6(5):278-81
Document Types: , Article
Countries: , Spain
Abstract: http://www.economiadelasalud.com/Ediciones/65/08_pdf/regulation.pdf
Condition Year Language Analysis type
, Health economics 2007 Spanish
 
 
The cost of zoster and post-herpetic neuralgia treatment in France.
Authors: Loock J, Le Pen C, Baptiste C, Bloch K, Valentin E, Bruxelle J, Berrut G, Gallais JL, Stahl JP
Affiliations: 
Publications: 
ISPOR
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract, Oral presentation
Countries: , France
Condition Year Language Analysis type
, Dermatology, Health economics 2007 English , Burden of illness
 
 
The relative cost-effectiveness of the fentanyl HCL patient-activated transdermal system (ITS) in acute post-operative pain management (POPM) in Greece.
Authors: Yfantopoulos I, Papanicolaou S, Papagiannopoulou V, Van Bellinghen LA, Annemans L
Affiliations: 
Publications: 
ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: , Belgium, Greece
Condition Year Language Analysis type
, Clinical practice, Health economics 2007 English , Cost effectiveness
 
 
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies.
Authors: Tunis SL1, Pelletier EM1, St. Charles M1, McEwan P2
Affiliations: 1IMS Health, Inc., Watertown, MA, USA, 2
Publications: 
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Meeting, Dublin, Ireland, October 2007
Document Types: , Workshop
Countries: , USA
Condition Year Language Analysis type
, Health economics, Methodology, Miscellaneous 2007 English , Retrospective database analysis
 
 
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
Authors: Van Staa TP, Kanis JA, Geusens P, Boonen A, Leufkens HG & Cooper C
Affiliations: Utrecht University, Utrecht, The Netherlands
Publications: 
Value Health. 2007 Sep-Oct;10(5):348-57.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17888099
Condition Year Language Analysis type
, Health economics, Womens Health 2007 English , Retrospective database analysis
 
 
EL NUEVO PACIENTE: Los retos de la información sobre salud y medicamentos [The new patient, Information challenges on health and drugs]
Authors: Badia X, Valentín C
Affiliations: 
Publications: 
Madrid: MSD y Defensor del Paciente de la Comunidad de Madrid; 1st ed. Madrid 2006:13-58
Document Types: , Book chapter
Countries: 
Condition Year Language Analysis type
, Health economics 2006 Spanish
 
 
Use of EQ-5D questionnaire in economic evaluations
Authors: Betegón L,. Lara N, Badia X.
Affiliations: 
Publications: 
XXVII Jornadas de Economía de la Salud (AES). La Coruña 6-8 June
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 Spanish , Economic evaluation
 
 
Carer's perspective ON the valuation OF schizophrenia-related health states USING the assessment OF quality OF life questionnaire AND the EQ5D
Authors: Adams J, Le Reun C, Crowley S, Eggleston A
Affiliations: 
Publications: 
Document Types: , Oral presentation
Countries: , Australia
Condition Year Language Analysis type
, Health economics 2006 English , Quality of life
 
 
Review of the use of the EQ5D in cost-utility analysis.
Authors: Betegón L, Badia X.
Affiliations: 
Publications: 
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Review
 
 
Review of the use of the Proxy version of the EQ-5D.
Authors: Lara N, Badia X.
Affiliations: 
Publications: 
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Review
 
 
Towards a better QALY model.
Authors: Abellán-Perpiñán J.M., Pinto-Prades J.L., Méndez-Martínez I, Badia Llach X.
Affiliations: 
Publications: 
Health Econ 2006;15:665-76
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Quality of life
 
 
When the direct to patient information in health and prescription drugs is already a fact through Internet.
Authors: Badia Llach X, Alonso-Rodríguez Piedra N.
Affiliations: 
Publications: 
Rev Esp Econ Salud 2006;5(5):272-5
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
The new patient: the challenges of health and drugs information.
Authors: Badia X, Valentín C.
Affiliations: H.O.R. Europe, a unit of IMS
Publications: 
Madrid: MSD y Defensor del Paciente de la Comunidad de Madrid; 1st ed Merck Sharp & Dohme de España S.A, Madrid 2006;13-58
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Review
 
 
Visados de inspección: ¿garantía del uso adecuado de los medicamentos o medida de control del gasto?
Authors: Gutiérrez Nicuesa L, Magaz Marqués S, Badia Llach X.
Affiliations: 
Publications: 
Aten Prim;37(5):278-86
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 Spanish
 
 
The Role of Pharmacoeconomics in US Managed Care Formulary Decisions: A Case Study
Authors: Minshall M
Affiliations: 
Publications: 
Pharma Pricing & Reimbursement, February 2007, pp46-50
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Assessment of the economic value of the INTERCEPT Blood System in Belgium.
Authors: Moeremans K; Annemans L.
Affiliations: 
Publications: 
Transfusion Medicine, 2006; 16:17-30
Document Types: , Manuscript in preparation
Countries: , Belgium
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Is it efficient to inform the patient about the new drugs? An economic model for Spain.
Authors: Badia X.
Affiliations: 
Publications: 
Forum on ""New challenges for the patients"", Madrid (Spain) 25 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Socioeconomic perspective of patient information.
Authors: Badia X.
Affiliations: 
Publications: 
Health Law Congress, Madrid (Spain) 19-20 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Health outcomes research: economic evaluation of pain.
Authors: Badia X.
Affiliations: 
Publications: 
VI expert meeting on socioeconomic issues of pain. Salamanca (Spain) 25 September
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Economic evaluation in Spain: current situation.
Authors: Badia X.
Affiliations: 
Publications: 
VI Jornada de Seminarios. Health Economics (Revista Española de Economía de la Salud, IESE, Fundamed), Madrid (Spain) 26 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Health-related quality of life in Outcomes Research.
Authors: Badia X.
Affiliations: 
Publications: 
VIII Jornadas Conjuntas de las Áreas 9 y 10 de Atención Primaria. The expectations and the achievements: we measure what we do or we do what we measure?, Getafe (Spain) 11 May
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Patient-Reported Outcomes (PRO).
Authors: Badia X.
Affiliations: 
Publications: 
XXIV Congreso de la Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Extension and implications of Health Outcomes Research(HOR).
Authors: Badia X.
Affiliations: 
Publications: 
XXIV Congreso of the Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Premature mortality associated to obesity in Spain: Adjusted Life Years.
Authors: Betegón L, Oliva J, Echevarria A, Badia X.
Affiliations: 
Publications: 
XXVI Jornadas de Economía de la Salud (Spanish Association on Health Economy, AES), Toledo (Spain) 23-26 May
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Recent policy initiatives in the Australian national reimbursement system that have reduced cost dramatically
Authors: Peter Davey.
Affiliations: 
Publications: 
ISPOR 11th Annual International Meeting
ISPOR 11th International Meeting, 20-24 May 2006 Philadelphia, Pennsylvania, USA. Podium presentation.
Document Types: , Oral presentation
Countries: , Australia
Condition Year Language Analysis type
, Health economics, Health policy 2006 English , Pricing & Reimbursement
 
 
Assessing quality of life of rare diseases patients in Spain. ERES STUDY.
Authors: Badia X, Layola M, Pérez P, Avellaneda A, Izquierdo M.
Affiliations: 
Publications: 
13th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Lisbon (Portugal) 11-14 October
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Economic advantages and time savings of using oxaliplatin concentrated solution versus osaliplatin lyophilised powder for infusion
Authors: Favier B, Spath HM, Anhoury P, Pacull A
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Validation of the patient’s attitudes and perceptions towards HAART questionnaire.
Authors: Fumaz C, Knobel H, Segador A, Lorenzo A, González J, García Pulgar M, Badia X, Perulero N.
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Patients and physicians perceptions towards subcutaneous treatment.
Authors: Knobel H, Fumaz CR, Segador A, Lorenzo A, González J, García Pulgar M, Perulero N.
Affiliations: 
Publications: 
8th International Congress on Drug Therapy in HIV Infection, Glasgow (UK) 12-16 November
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Estimating utility in rotavirus gastroenteritis in children under five in the UK
Authors: Martin A, Cotrell S
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Health economics 2006 English
 
 
An observational health-economic analysis of the treatment of patients with voriconazole in a real-life setting
Authors: Van Campenhout H, De Mees V, Marbaix S, Annemans L
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Belgium
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Auswirkungen der Gesundheitsökonomie in Industrie und Politik [Effects of Health Economy in Industry and Politics]
Authors: Fricke F-U
Affiliations: IMS Health, Nuremberg, Germany
Publications: 
Daumann F. et al.: Wettbewerb und Gesundheitswesen: Konzeption und Felder ordnungsökonomischen Denkens, Budapest, 2006, 335-344
Document Types: , Book chapter
Countries: , Germany
Condition Year Language Analysis type
, Health economics 2006 German
 
 
Quantifying the impact of fear of hypoglycaemia on quality of life
Authors: Walters N, Gordois A, Brown A, Lindsay P, Gonzalo F, Comas S
Affiliations: 
Publications: 
ISPOR 9th Annual European Congress
Document Types: , Poster
Countries: , Australia
Condition Year Language Analysis type
, Diabetes, Health economics 2006 English , Burden of illness
 
 
When Direct-to-Patient health and prescription drug information is already a reality through the Internet.
Authors: Badia X, Alonso-Rodríguez Piedra N
Affiliations: 
Publications: 
Rev Esp Econ Salud 2006;5(5):272-5
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 Spanish
 
 
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
Authors: Lamotte M, Annemans L, Evers T, Kubin M
Affiliations: 
Publications: 
Pharmacoeconomics, 2006, 24(2): 155-169
Pharmacoeconomics; 24:155-69
Document Types: , Article, Manuscript in preparation
Countries: , Belgium
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2006 English , Economic evaluation
 
 
Economic evaluation of surgical treatment vs. Imiquimod 5% cream in patients with Superficial Basal Cell Carcinoma
Authors: Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA.
Affiliations: 
Publications: 
Br J Dermatol. 2007 Apr;156(4):769-71.
Document Types: , Article
Countries: , Spain
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract?CRETRY=1&SRETRY=0
Condition Year Language Analysis type
, Health economics, Oncology 2006 English
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.